Introduction {#S1}
============

Over the past several decades, an extensive amount of scientific attention has been invested in the field of nanotechnology. Significant advances have been made in understanding the unique behaviors of matter with nano-scale dimensions. This progress has facilitated the capacity for manipulation of material properties to optimize their functional utility. Subsequently, nanomaterials have proven useful in diverse applications ranging from pharmaceutics and energetics to transportation and electronics. The exponential growth of the nanotechnology field has left few sectors unaffected by its momentum, as the global nanotechnology market has been valued at over \$20 billion US (Nanomaterials Future Markets 2015). Although the resounding impact of these technological advancements has generated comparisons to the impact of the industrial revolution, the expansion of nanotechnology has also generated several notable concerns. In addition to the environmental, legal, ethical, and regulatory challenges imposed by the expanding presence of nanotechnology, the potential risk for adverse health effects following exposure to nanomaterials has also become a major concern.

As a result, a unique discipline of toxicology has emerged to evaluate the potential health effects of nanomaterials. Nanotoxicology studies have consistently demonstrated that the unique properties of nanomaterials that render their industrial functionality also implicate unique interactions with biological systems. A general correlation between decreasing size and increased toxic potential has been observed for many nanomaterials ([@R438]). However, additional physical and chemical properties of nanomaterials have been implicated in their biological activity. Nanomaterials exist in various morphologies ([Figure 1](#F1){ref-type="fig"}) with diverse surface textures, and can assume differing degrees of agglomeration. These physical properties contribute to variations in their chemical properties, which include surface charge, dissolution kinetics, and surface reactivity (Oberdorster et al. 2005; [@R55]; [@R119]).

One of the greatest challenges presented to nano-toxicologists arises from the discord between the rapid emergence of vast quantities of new nanomaterials and the significant amount of time and resources required to evaluate the safety of each material individually. A novel risk assessment approach proposed to mitigate this issue involves delineation of relationships between specific physicochemical properties and toxicological modes of action ([@R221]; [@R45]). Subsequently, emerging materials can be categorized by this scheme, providing preliminary safety information and prioritization of resources for *in vivo* studies ([@R425]). Significant advancements have been made using this approach with respect to toxic effects on the lungs, but the correlation of nanomaterial physicochemical properties with adverse effects on other systems, such as the immune system, are less clear.

In addition to protecting the host from both endogenous and exogenous threats, the immune system is a critical regulator in hundreds of other disorders, as inflammation is a critical component in the pathophysiology of nearly all chronic diseases states ([@R364]). Accordingly, deviations in optimal immune functioning can have resounding effects on host health, whether polarized towards being either stimulatory or suppressive in nature. One of the immunological disorders presenting a significant and continually expanding global public health burden is allergy. The term "allergic disease" refers to a collective assortment of disorders involving diverse inciting agents, underlying immunological mechanisms, and clinical manifestations. However, all hypersensitivity disorders are characterized by commonality in hyperactivation of adaptive immune responses directed at otherwise innocuous exogenous antigens ([@R363]).

Rates of allergic disease have been on the rise for decades, and the American Academy of Allergy, Asthma, and Immunology reports that worldwide, sensitization rates to one or more common allergens are approaching 40--50% in school-aged children (AAAAI 2015). In the United States, allergic diseases are the sixth leading cause of chronic illness with an annual cost exceeding \$18 billion US (Centers for Disease Control and Prevention 2017). Although the development of allergy is dependent on a multitude of genetic, behavioral, and environmental factors, exposures to immunotoxic agents are a major underlying contributor to allergic diseases ([@R44]). Immunotoxic agents with the capacity to impact allergic disorders generally exert one of two effects. First, the agent can act as an allergen or sensitizer. Following exposure to these agents, the resultant adaptive immune response is specific to the agent and subsequent encounters trigger allergic reactions. Contrarily, agents can augment immunological processes involved in allergic disorders specific to differing agent. These agents are often referred to as "adjuvants" or "immuno-modulators" and their effects can range from increasing host susceptibility to sensitization, decreasing the allergen dose required to induce sensitization, decreasing the dose required to elicit allergic responses, or exacerbating the severity of allergic responses ([@R543]).

As the nanotechnology market continues to expand and the global prevalence of allergic disease continues to increase, the knowledge gap regarding the immunotoxic potential of nanomaterials is becoming increasingly relevant. Specifically, the capacity for nanomaterials to cause or exacerbate allergic disease remains largely unknown, which is particularly concerning with respect to a specific class of nanomaterials. Metal-based nanomaterials (e.g. metallic, oxidic, alloy, and salt forms) are one of the classes of nanomaterials being produced in the largest quantities. Noteworthy metal nanomaterials, their applications, and corresponding rates of production are shown in [Table 1](#T1){ref-type="table"}. These emerging materials present a specific concern with respect to allergy, as many of the metal-based nanomaterials being manufactured in large volumes are comprised of metals known to cause allergic contact dermatitis (ACD), asthma, and allergy adjuvancy ([@R507]; [@R421]).

Metal nanomaterials are being increasingly incorporated into nano-enabled products and consumer goods, increasing the potential for exposures in the general public ([@R494]). Although the unknown immune effects of many metal nanomaterials present a risk for consumers, workers involved in the manufacture, handling, and transportation of metal nanomaterials present a population particularly susceptible to adverse allergic effects. The National Science Foundation estimates that by 2020, at least 2 million workers in the United States alone will be employed by nanotechnology-related fields ([@R397]). New nanomaterials are continually being developed, and workers are often the first individuals in society to encounter emerging materials, and often in much greater quantities than consumers. Moreover, occupational settings are known to contribute to the development and progression of allergic diseases ([@R17]). Of the 24 million Americans affected by allergic asthma, 10--25% of adult cases are related to workplace conditions ([@R372]). Skin allergies are even more common, affecting an estimated 15--20% of the general population, wherein an estimated 25--60% of ACD cases are related to occupational settings ([@R93]; [@R366]).

Several specific concerns have emerged with respect to metal nanomaterials and their potential effects on allergic disease. First, the characteristic size profile of metal nanomaterials may confer enhanced potential for skin penetration and more efficient deposition in the lungs, circumventing one of the major barriers associated with limiting adverse immune effects induced by larger-sized metals. Secondly, the exposure threshold required for dermal and respiratory sensitization by metal nanomaterials may be lowered as a result of their unique chemistry. Lastly, the induction of inflammation and tissue injury caused by many metal nanomaterials may serve as an adjuvant, promoting the development of allergic disease to environmental allergens or exacerbating the severity of established allergic conditions. This review aims to summarize current scientific knowledge regarding these concepts. In addition to dermal and respiratory studies that examine specific metal nanomaterial effects, studies designed to delineate the role of physical and chemical properties in these effects are emphasized. Finally, considerations and knowledge gaps in the field are highlighted as potential directions for future research.

Metals and allergic disease {#S2}
===========================

Metals are a class of agents associated with expansively diverse immune effects including irritancy, autoimmunity, sensitization, and adjuvancy ([@R238]). The potential for such diverse biological effects is reflective of the expansive potential speciation of metals, which can include elemental forms, ions, salts, and organified compounds ([@R473]). Moreover, as exemplified by the transition metal series, many metals exist in and transition between different oxidation states that have distinctive immunological activity ([@R18]; [@R75]). The chemical behavior unique to these potential states dictates the molecular and cellular interactions responsible for metal immunogenicity. Since many of these properties are known to be altered on the nano-scale, metal-induced immune effects with relevance to allergy are detailed, with emphasis on specific processes subject to impact by metal nanomaterial physicochemical properties.

Metals and dermal allergy {#S3}
-------------------------

The most common metal-induced allergic disorder of the skin is ACD, a T-cell-mediated delayed-type hypersensitivity response. Dermal sensitization and the subsequent induction of ACD requires several key molecular and cellular events ([Figure 2](#F2){ref-type="fig"}), which have been outlined in an adverse outcome pathway (AOP) by the Organization for Economic Co-operation and Development (OECD) (OECD 2014).

The preliminary requirement for skin sensitization is bioavailability of the sensitizing agent. Since a primary function of the skin is to serve as an effective barrier between the host and environment, the sensitizing potential of many antigens is limited by their capacity to evade this barrier ([@R179]). Passage through the uppermost layers of the epidermis is heavily dependent on antigen physical and chemical properties. Likewise, most dermal sensitizers tend to be low molecular weight (LMW, \< 500 Daltons) chemicals with adequate lipophilicity (logP \~2) ([@R63]; [@R201]). Metals associated with skin sensitization present the greatest concern when formulated as soluble salts that release ions capable of penetrating the physical barrier presented by the epidermis ([@R92]; [@R220]).

The next steps in the skin sensitization AOP involve the molecular initiating event of skin sensitization-antigen formation. The small size required for antigen passage through the stratum corneum is not conducive with cellular recognition ([@R11]). As a result, most skin sensitizers are referred to as haptens, which must acquire or possess inherent chemical reactivity that facilitates binding to carrier molecules ([@R49]; [@R64]). This process generates adequate size for recognition by an antigen-presenting cell (APC). The APC most frequently implicated in dermal sensitization is the resident dendritic cell (DC) of the epidermis, the Langerhans cell (LC) ([@R476]).

In addition to uptake of the hapten/carrier complex, activation of LC requires an additional antigen-nonspecific signal indicative of an elevated threat level. Many mediators capable of fulfilling this signal are released by non-immune cells including keratinocytes in response to injury ([@R88]). Presence of both antigen-specific and nonspecific signals induce LC maturation, upregulation of co-stimulatory molecules, antigen processing, and migration to the lymph nodes ([@R482]).

Once the LC reaches the lymph nodes, the processed hapten is presented via major histocompatibility Class I (MHC I) molecules to naïve CD8^+^ T-lymphocytes until recognition occurs by antigen-specific T-cell receptor (TCR). Given adequate costimulatory signals from the LC, T-lymphocytes undergo proliferation producing a pool of clonal antigen-specific effector T-cells. The T-cells enter the circulation, and following resolution of inflammation, a subset of these effector cells will survive and become memory T-cells, completing the process of sensitization.

Upon future exposures to the allergen, memory and effector T-cells are recruited to the site of exposure where CD8^+^ T-cells exhibit immediate cytotoxic effector functions. CD4^+^ T-helper (T~H~) of the T~H~1 phenotype have regulatory roles in ACD and produce high levels of the cytokines interleukin (IL)-2 and interferon (IFN)-γ, contributing to inflammatory cell recruitment ([@R412]; [@R482]). Within 48 h, the inflammatory process originally orchestrated to destroy the antigen results in the clinical manifestations of ACD, including localized skin redness, swelling, and itching at the site of allergen contact.

Metals are among the most common inducers of ACD in the general population. Patch test studies have generated data from thousands of subjects and reveal that the most common inducers of metal ACD are nickel, gold, cobalt, and chromium ([@R31]). Interestingly, studies using subjects exclusive various geographical locations have demonstrated that these four metals are consistently problematic with respect to ACD worldwide ([@R196]; [@R288]; [@R131]; [@R62]; [@R80]; [@R333]; [@R206]; [@R272]; [@R209]; [@R276]; [@R253]). Though less frequently associated with ACD, copper, aluminum, and platinum group metals are also known to cause skin allergy in some individuals ([@R166]; [@R34]; [@R108]; [@R105]).

Metals and respiratory allergy {#S4}
------------------------------

Metals are also associated with respiratory allergy and IgE-mediated asthma. An AOP specific to the events of respiratory sensitization has not been adopted by the OECD, but many of the same steps of the dermal sensitization AOP are involved in the development of asthma. Accordingly, bioavailability of the sensitizing agent is also a preliminary limiting factor in respiratory sensitization potential. Since the primary function of the respiratory tract is to facilitate gas exchange between the host and environment, it is particularly vulnerable to adverse effects from a diverse assortment of agents in the inhalable (\< 20 μm) and respirable size range (\< 10 μm) ([@R100]). Likewise, bioavailable metals capable of sensitizing the respiratory tract are not limited to ions, like in the skin ([@R254]). Respirable metals may be encountered as particulate matter, vapors, or fumes and can be constituents of compounds including oxides, sulfides, and salts, or as complexes with ammonia, carbon monoxide, and organic nitrogen ([@R268]).

Since both low and high molecular weight (HMW) agents are capable of inducing asthma, the molecular initiating events of respiratory sensitization may differ accordingly. Similar to the skin, pulmonary immune responses following inhalation of metals can be nonspecific and self-limiting, or can result in the recruitment of the adaptive immune system. Lung-resident DC take up antigen, and given adequate second signals, the antigen is processed and DC migrate to the lung-draining lymph nodes. Here, the peptide is presented to naïve CD4^+^ T-lymphocytes along with costimulatory molecules, resulting in the preferential expansion of the T~H~^−2^ phenotype lymphocytes. These cells produce high levels of IL-4, IL-5, and IL-13, and stimulate isotype switching and allergen-specific IgE-production by B-cells. The Fc portion of secreted IgE is bound to FceRI receptors present on tissue-resident mast cell surfaces and circulating basophils, exposing the antigen-recognizing motif, completing the sensitization process ([@R498]).

Upon subsequent encounters, the allergen is bound by allergen-specific IgE on the surface of mast cells and basophils. Binding induces crosslinking of receptors and the subsequent release of preformed mediators such as histamine, beginning the anaphylactic cascade responsible for the early asthmatic reaction experienced minutes after antigen encounter. Acute clinical manifestations of allergic asthma range from rhinitis and bronchoconstriction to anaphylactic shock. The late phase asthmatic response occurs 4--6 h later as a result of mast cell mediators and recruitment of inflammatory cells ([@R379]). Clinical presentations of the late phase asthmatic response tend to be more severe than early phase responses, and include excessive mucus production, increased vascular permeability, and airway constriction. Chronic cycles of allergic inflammation and subsequent repair are associated with structural alterations in the airways that can have physiological implications, such as a decline in lung function ([@R103]).

Compared to metal-induced ACD, metal-induced asthma occurs far less frequently. Cases tend to be isolated to individuals working in occupations involving metalwork where metal fumes, dust, or vapors are generated and inhaled ([@R514]). Nickel, chromium, cobalt, vanadium, zinc, platinum and aluminum have all been associated with cases of occupational asthma ([@R318]; [@R162]; [@R268]). However, metal-specific IgE has only been implicated in cases caused by nickel, platinum, chromium, and cobalt ([@R277]; [@R315]; [@R452], [@R453], [@R454]; [@R223]). Metal-specific IgG molecules have also been implicated in cases of cobalt and platinum-induced asthma ([@R368]; [@R70]). The presence of metal-specific IgE has also been confirmed in the absence of asthmatic symptoms, emphasizing the potential for numerous immunological mechanisms in metal-specific asthma ([@R102]; Tončić et al. 2013).

Metals and allergy adjuvancy {#S5}
----------------------------

In addition to their potential to induce sensitization, metals are also associated with the capacity to modulate allergic responses to nonmetal allergens. Contrasted with the consistent, sequential series of cellular processes involved in allergic sensitization and elicitation, adjuvant effects can emerge as a result of various mechanisms in various phases of allergic disorders ([Figure 3](#F3){ref-type="fig"}).

An example of metal adjuvant effects on the development of adaptive immune responses is best demonstrated by aluminum hydroxide, which is one of the most frequently used vaccine adjuvants. When administered with poorly-immunogenic antigens, aluminum hydroxide induces adequate stimulation of the innate immune system to generate antigen-specific immunological memory. Mechanisms of immunopotentiation associated with aluminum hydroxide include triggering release of alarmins, activation of inflammasomes (intracellular multi-protein complexes involved in innate immune responses), and DC activation; however, numerous other mechanisms including immune cell recruitment and activation, modulated cytokine production, and altered antigen delivery kinetics, can also enhance sensitization ([@R322]; [@R4]).

Similarly, metals are also associated with adjuvant effects on established allergic conditions, as demonstrated by metal-rich ambient air pollution, which is known to exacerbate the severity of asthmatic responses to environmental allergens ([@R121]; [@R417]). Adjuvant effects on allergic elicitation can involve mechanisms including induction of pulmonary oxidative stress, enhanced degranulation of mast cells, and recruitment of inflammatory cells ([@R502]; [@R125]).

Unique properties associated with metal immune effects {#S6}
------------------------------------------------------

Metals are known to induce many unique immune effects implicated in allergic disease. With respect to sensitization, the modulation of innate immune reactivity by some metals has been associated with their immuno-genicity. For example, some metal ions are known to produce functional mimicry of pathogen-associated molecular patterns (PAMP) ([@R421]). Gold ions have the capacity to bind and activate Toll-like receptor (TLR)-3, while nickel, cobalt, and palladium ions have the capacity to bind and activate human TLR-4 ([@R422]; [@R385], [@R386]). The subsequent induction of pro-inflammatory signaling generates the antigen nonspecific signals required for DC activation, promoting sensitization.

Metals are also known to modulate mechanisms of communication between innate and adaptive immune cells. Accordingly, antigen presentation is another step in allergic sensitization that is subject to interference by metals. Beryllium and noble metals have been shown to induce structural alterations in MHC molecules, impacting subsequent interactions with TCR ([@R87]; [@R107]). Similarly, peptide-independent linking of MHC and TCR by nickel has been demonstrated ([@R118]; [@R475]). Adaptive immune responses can also be affected by metals, as demonstrated by CD4^+^ nickel-specific T-cell clones, which were shown to cross-react when presented with other transition metals including copper and palladium ([@R312]; [@R376]).

Many of the unique immune effects associated with metals emerge as a result of their capacity to alter molecular and cellular interactions on a biochemical level. Accordingly, their modulation of processes involved in allergic disease is critically dependent on physicochemical properties including special geometry, oxidation state, and solubility ([@R424]; [@R214]). Many of these properties are altered in nanoparticulate form, suggesting that metal nanomaterials may exhibit novel mechanisms of immune interaction with implications for allergic disease.

Metal nanomaterials and dermal hypersensitivity {#S7}
===============================================

The potential for adverse immune effects following dermal exposure to metal nanomaterials is a growing concern due to their increasingly frequent incorporation into consumer goods intended to have prolonged contact with the skin ([@R525]). The unique optical properties of titanium dioxide nanoparticles (TiO~2~ NP) and zinc oxide nanoparticles (ZnO NP) have led to their incorporation in sunscreens and cosmetics for their protective effects against ultraviolet radiation (UVR) ([@R460]; [@R532]). Silver nano-particles (AgNP) are being incorporated into clothes, medical textiles, toys, and cleaning products due to their antimicrobial properties, and silica-based nanoparticles (SiNP) have been frequently used in cosmetics and as a coating material to alter the properties of other materials ([@R72]; [@R485]). Likewise, the dermal effects of TiO~2~ NP, ZnO NP, AgNP, and SiNP are a particular concern with respect to the general public ([@R509]). These nanomaterials are also a concern for workers, but other metal nanomaterials with high rates of production (listed in [Table 1](#T1){ref-type="table"}) are also associated with dermal exposures in the workplace.

The potential for metal nanomaterials to penetrate the skin, induce dermal sensitization, and modulate skin allergy development/responses are the three main areas discussed in this section with respect to size and other physicochemical properties. In correspondence with the review of the literature, [Table 2](#T2){ref-type="table"} summarizes studies characterizing effects of individual metal nanomaterials on skin allergy. [Table 3](#T3){ref-type="table"} summarizes studies designed to examine effects of physicochemical properties of metal nanomaterials on dermal allergy. [Table 4](#T4){ref-type="table"} highlights key events involved in dermal sensitization and elicitation that have been shown to be subject to modulation by metal nanomaterials and their corresponding physicochemical properties.

Skin penetration and translocation studies {#S8}
------------------------------------------

Adverse immune effects following dermal exposure to an agent are heavily dependent on the degree to which the skin protects from its entry into the body. Likewise, one mechanism by which dermal exposure to metal nanomaterials may lead to increased potential for adverse immune effects compared to larger-sized metals is by size-mediated evasion of skin barrier function. Although it seems logical that the small size of nanomaterials would inherently provide increased opportunity for absorption via the skin, there is currently no general consensus on the skin-penetrating capabilities of nanomaterials as a collective class of agents ([@R499]; [@R24]; [@R483]).

Numerous studies have demonstrated that metal nanomaterials (\< 100 nm) can penetrate skin in various *in vivo* and *in vitro* models. Iron-based nanoparticles (FeNP), gold nanoparticles (AuNP), palladium nanoparticles (PdNP), nickel nanoparticles (NiNP), AgNP, SiNP, and metal-based quantum dots (QD) have all been associated with penetration of the skin ([@R25]; [@R68]; [@R113], [@R114]; [@R224]; [@R149]; [@R390]; [@R123]; [@R76]; [@R219]). Moreover, many of these studies have established a relationship between decreased particle size and increased potential for skin permeation ([@R404]; [@R464]; [@R287]; [@R388]). Hydrophobicity, surface charge, and morphology are additional properties that have been shown to be influential in the capacity for these nanomaterials to pass through the stratum corneum ([@R390]; [@R239]; [@R175]; [@R111]; [@R469]; [@R274]).

By comparison, the majority of studies investigating the skin-penetrating potential of metal nanomaterials have been conducted with ZnO NP and TiO~2~ NP and have not generated equally consistent findings. Numerous studies have demonstrated that the stratum corneum effectively restricts passage of TiO~2~ NP, irrespective of size shown to facilitate penetration of the skin by other metal nanomaterials. Repeated application of different forms of TiO~2~ NP did not lead to skin penetration in hairless rats, elevated levels of titanium in lymph nodes of minipigs, or penetration of human skin transplanted onto immunodeficient mice ([@R215]; [@R406]; [@R2]). Although TiO~2~ NP were shown to accumulate in and around furrows of the skin, microscopic analysis was used to confirm that 20--100 nm TiO~2~ NP remained restricted to the uppermost 3--5 layers of corneocytes of the stratum corneum ([@R228]; [@R374]; [@R130]; [@R435]). Contrarily, a few studies using TiO~2~ NP-containing sunscreens have reported penetration of particles into the viable epidermis of human skin ([@R470]; [@R71]; [@R320]).

Similar observations have been reported for ZnO NP. Despite associations with hair follicles, ZnO NP were not capable of penetrating the stratum corneum in multiple models, irrespective of alterations in size, morphology, and surface characteristics ([@R427]; [@R544]; [@R244]). However, ion release from ZnO NP and ZnO NP-containing sunscreens has been observed, highlighting a potential risk associated with soluble metal nanomaterials ([@R160]).

Adverse effects following dermal exposure to nanomaterials may result from penetration of the particulate material or ions released from the parent material. Likewise, physicochemical properties of interest may be differentially implicated in effects associated with soluble and insoluble metal nanomaterials. With respect to soluble materials, properties associated with accelerated ion release may indicate increased potential for skin penetration ([@R231]; [@R165]; [@R476]). The rate of ion release is proportional to specific surface area (SSA; surface area per mass unit), which is exponentially increased on the nano-scale ([@R237]; [@R539]; [@R235]). This concept explains the observation that application of sunscreens containing ZnO NP caused greater increases in blood, urine, and organ Zn ion levels than sunscreens containing larger-sized ZnO particles ([@R137], [@R138]; [@R344]). Moreover, the manipulation of properties with implications for dissolution potential, such as particle coating, vehicle, and suspension pH have been shown to promote Zn ion release from ZnO NP following dermal exposure ([@R244]; [@R160]).

Although penetration through corneocytes of the stratum corneum is the primary pathway associated with skin penetration by materials, appendages including hair follicles, sebaceous glands, sweat glands, and skin folds can mediate an additional mechanism of skin penetration. This pathway has notable relevance to nanomaterials, as evidenced by the utility of the trans-follicular delivery route for nano-scale pharmaceutics and vaccines ([@R271]). Compared to the thickness of the stratum corneum, which measures 10--20 mm, hair follicles can reach a tissue depth of 2000 mm ([@R480]). Since the base of hair follicles extends into the dermis and receives generous lymph and blood supply, they may promote access into the circulation ([@R101]). Moreover, hair follicles can serve as a potential reservoir, promoting accumulation of nanomaterials. Retention in hair follicles can extend the duration of exposure 10-fold, raising specific concerns for continual ion release ([@R227], [@R226], [@R225]; [@R362]; [@R273]). This pathway of skin penetration may also favor immune responses since hair follicles are surrounded by dense networks of LC and specialized keratinocyte subpopulations known to have critical roles in the early events of sensitization ([@R479]; [@R499]; [@R321]).

The diameter of hair follicles can vary greatly in response to anatomical location, but the smallest follicles tend to be located on the forehead and forearm and measure between 66 and 78 mm ([@R346]). Interestingly, the optimal size for penetration of hair follicles is significantly larger than the \< 100 nm size range associated with increased skin penetration of several metal nanomaterials. Particles with 600--700 nm diameter have been shown to deposit in the deepest depths of hair follicles, suggesting that agglomerates of nanomaterials in this size range are potentially more hazardous than primary particles ([@R362]; [@R225]). Furthermore, preferential accumulation in follicles has been observed in hydrophobic and neutrally-charged nanomaterials ([@R273]).

Although physicochemical properties of metal nanomaterials have been shown in some instances to impact skin penetration, an assortment of host factors can also impact this process. Variations in epidermal thickness, integrity, degree of hydration, and skin pH, all of which may further differ between gender, can greatly influence skin permeability ([@R411]; [@R435]; [@R85]). However, the role of disrupted skin barrier integrity is one of the most commonly-examined host factors with applicability to allergic disease since skin permeability can be increased 4--100 times in individuals with skin allergy (Larese [@R233]).

Scratching to alleviate itching associated with allergic skin lesions leads to mechanical damage to the upper layers of skin. Similar degrees of damage have been shown to increase *in vivo* penetration of some metal nanomaterials in humans and rodents ([@R537]; [@R132]; [@R393]; [@R382]). *In vitro* simulations using a human skin model called the Franz Method have demonstrated increased capacity for passage through damaged skin by 25 nm AgNP, 6 nm PtNP, 5 nm rhodium nanoparticles (RhNP), 10 nm PdNP, 78 nm NiNP, and 80 nm CoNP ([@R232]; [@R234]; [@R291]; [@R76]; [@R114]). Contrarily, studies have shown that penetration of various sizes of TiO~2~ NP and ZnO NP are not increased in skin damaged by chemical irritants, tape-strip-ping, hair removal, or mechanical force ([@R435]; [@R250]; [@R296]; [@R77]; [@R515]; [@R245]).

A few *in vivo* studies have also investigated effects of skin barrier dysfunction resulting from existing skin allergy on the penetration of metal nanomaterials (Larese [@R233]). In a mouse model of skin allergy, ZnO NP skin penetration of allergic skin was size-dependently increased, as 240 nm ZnO particles did not penetrate the skin to a similar degree as 20 nm ZnO NP ([@R177]). Studies using nonmetal nanomaterials have also demonstrated that penetration of nanomaterials in allergic skin is size-dependent ([@R483]). ZnO NP were also shown to penetrate allergic skin *ex vivo* using human skin samples ([@R468]). Contrarily, application of 35 nm ZnO NP to skin of living human subjects with atopic dermatitis did not lead to penetration into viable skin ([@R250]). Discrepancies between these studies may be reflective of varying exposure durations, as the study reporting penetration involved continuous exposure of up to 2 weeks, compared to the 4-hr exposure wherein no penetration was observed.

Comparatively, equally prolonged exposure to AgNP-containing textiles did not lead to increased skin penetration in individuals suffering from atopic dermatitis compared to control subjects. Sleeves containing silver particles (30--500 nm) were worn by human subjects for 8 h a day for 5 consecutive days, following which levels of AgNP and aggregates in the skin were quantified. Compromised skin barrier was not associated with increases in AgNP skin accumulation; moreover, no differences in urine Ag levels were observed, indicating that atopic dermatitis did not impact the absorption of ions released from the textiles either ([@R377]; [@R37]).

Discrepancies in findings regarding the importance of skin barrier integrity on metal nanomaterial skin penetration may be explained by several observations. The diverse degrees of epidermal barrier function disruption between studies represent a potential source of variation. Complete ablation of epidermal function is only observed in response to severe burns and lacerations; likewise, the diverse mechanisms of experimentally-induced disruptions of the stratum corneum should be compared cautiously. In addition, the pathogenesis of atopic dermatitis between experimentally-induced animal models and humans may explain some discordant findings. The severity of lesions between subjects of human studies is also subject to extreme variation, as well. Since chronic skin inflammation can result in epidermal thickening, enhanced barrier function is not uncommon in many skin disorders ([@R332]). Lastly, differences in exposure conditions and duration, test material formulation, and method of penetration assessment can also serve as a source of variation in conclusions between studies. A notable distinction should be made between test materials, since some studies used pristine metal nanomaterials, and others used commercially-available TiO~2~ NP/ZnO NP-containing sunscreens. As noted by [@R138], their observations regarding ZnO NP skin penetration may have been subject to modulation by excipients of the commercial sunscreens used in their study. The sunscreen contained isopropyl myristate, a chemical known to enhance the permeability of the skin, as well as EDTA, a chelating agent which may have influenced the release of ions from ZnONP.

In addition to nanomaterial properties and host factors known to influence the capacity for metal nanomaterials to penetrate the skin, environmental factors may also impact this process. One environmental factor with particular relevance to metal nanomaterials and their use in sunscreens is UVR. Although high levels of UV exposure and subsequent sunburn can significantly disrupt epidermal barrier function, low doses of UV exposure are also known to compromise the integrity of the epidermis ([@R513]; [@R159]; [@R38]). Accordingly, several studies have shown that UV exposure prior to topical application of nanomaterials results in greater depth of penetration by ZnO NP, TiO~2~ NP, and QD ([@R310]; [@R306]; [@R309]). Moreover, UVR can induce alterations in physicochemical properties of metal nanomaterials that may facilitate their passage through the stratum corneum, such as agglomerate disaggregation and ion release ([@R284]; [@R32]; [@R541]; [@R270]).

Simultaneously, UVR-induced photoactivation of some metal nanomaterials can facilitate their penetration of the skin. *In vitro*, UVR-induced ROS production by TiO~2~ NP, QD, and ZnO NP has been associated with DNA damage, lipid peroxidation, and mitochondrial permeability in skin cells ([@R477]; [@R505]; [@R369]; [@R308]; [@R519], [@R518]). Subsequent cytotoxicity to dermal fibroblasts, keratinocytes, and melanocytes is another mechanism by which skin barrier integrity can become compromised as a result of UVR. *In vivo*, UVR-induced photoactivation of TiO~2~ NP has been associated with increased adherence to the skin, structural rearrangement of the lipid bilayer, and facilitation of large molecule transdermal penetration ([@R32]; [@R487]; [@R365]; [@R347]; [@R347]). Since the degree of ROS produced in response to UVR has been associated with nanoparticle surface area and reactivity, other related properties such as size, degree of agglom-eration, and surface modification may also contribute to skin penetration following UVR exposure ([@R443]; [@R182]; [@R529]; [@R516]).

Although UVR may contribute to adverse effects following dermal exposure to metal nanomaterials by facilitating skin penetration, it may also present a unique concern with respect to allergy. Many signaling pathways and pro-inflammatory mediators involved in sensitization have been associated with UVR-dependent photoactivation of metal nanomaterials ([@R317]; [@R391]). Moreover, UVR is known to modulate the immune status of the skin by a number of mechanisms. For example, UVA and UVB are known to augment costimulatory molecule expression, compromise antigen presentation, and induce apoptosis of LC ([@R392]; [@R433]; [@R430]). Subsequent effects on the immunological fate of metal nanomaterials on the skin have been demonstrated. In a mouse model, significant depletion of LC (\~80%) following UVR exposure increased skin penetration of QD, but resulted in lower levels of metal ion constituents in the lymph nodes ([@R309]).

Skin sensitization studies {#S9}
--------------------------

The skin sensitizing potential of metal nanomaterials has been investigated in a few studies using traditional *in vivo* approaches. SiO~2~ NP, ZnO NP, and TiO~2~ NP have all been incorporated into the Local Lymph Node Assay (LLNA) ([@R278]; [@R27]). Accordingly, it was demonstrated that topical exposure to 100 nm mesoporous and colloidal SiO~2~ NP, 7 nm SiO~2~ NP, and ZnO NP were not capable of inducing the 3-fold increase in lymphocyte proliferation associated with classification as a dermal sensitizer ([@R66]; [@R242]; [@R208]). Similarly, topical exposure to 25 nm TiO~2~ NP did not induce dermal sensitization in multiple studies; however, subcutaneous injection of equal doses resulted in significant increases in lymphocyte proliferation, suggesting that the inability for TiO~2~ NP to penetrate the skin might be a limiting factor in the potential to induce dermal sensitization ([@R352]; [@R22]).

The guinea pig maximization test (GPMT) is another *in vivo* technique used to evaluate dermal sensitization potential that has been employed in the investigation of several metal-based nanomaterials. In one study, five UV-absorbing materials containing SiO~2~ NP, ZnO NP, and TiO~2~ NP were assessed. One out of 10 animals exhibited slight erythema following topical exposure to the ZnO NP and TiO~2~ NP-containing agents, leading to their classifications as mild skin sensitizers ([@R375]). In another study, 1 of 20 animals exhibited discrete patchy erythema following intradermal injection with 10 nm AgNP, leading to its classification as a weak skin sensitizer ([@R212]). Similarly, AgNP were classified as a Grade II (mild sensitizer) after 2 of 10 guinea pigs exhibited lesions 48 h after application of AgNP-containing sterile gauze (Zelga et al. 2016). However, similar AgNP-containing dressings were actually shown to improve the healing of burn wounds in rats over an 18-d period as compared to rats with dressings lacking AgNP, but the study only examined the localized effects ([@R350]). The GPMT has also been used to demonstrate that surface-modified FeNP and hydroxyapatite nanoparticles did not induce skin sensitization ([@R122]; [@R303]).

The sensitization potential of 5 and 10 nm AgNP was investigated by [@R151] in a mouse model. Mice were injected with AgNP or Ag ions and lipopolysaccharide (LPS) once a week for 4 weeks, and then intradermally challenged. Interestingly, mice administered Ag ions in the sensitization phase did not develop ear swelling following challenge with any form of Ag. Contrarily, AgNP exposure induced sensitization, wherein the smaller AgNP appeared to have stronger sensitizing potential, which was dependent on CD4^+^ T-cells and IL-17a, but not IFNγ. Moreover, ear swelling was observed in response to additional sizes of AgNP (50 and 100 nm) and Ag ions, suggesting that the immune response is not nanoparticle-specific. Further examination revealed that 3 nm NiNP was also capable of inducing sensitization in the model, whereas minimally-ionizable 10 nm AuNP and 10 nm SiNP were not ([@R151]).

In addition to *in vivo* approaches to assess skin sensitization, three non-animal alterative assessment methods based on different steps of the skin sensitization AOP are currently validated by the OECD. While metal nanomaterials have not been incorporated into any of the assays, studies with similar cell lines and endpoints have indicated that many metal nano-materials can induce effects similar to those of other skin sensitizers.

The Direct Peptide Reactivity Assay (DRPA) is an *in chemico* assay based on the requirement for haptens to bind skin proteins to acquire immunogenicity. Accordingly, the molecular imitating event of dermal sensitization is evaluated by quantification of reactivity of an agent towards synthetic lysine and cysteine residues ([@R124]). While some studies have investigated metal nanomaterials and their interactions with proteins and specific amino acids, implications for their capacity to form hapten/carrier complexes are still unclear. However, cysteine has been associated with decreased stability, increased dissolution, and accelerated ion release from metal alloy nanoparticles and AgNP ([@R140]; [@R394]; [@R459]). Moreover, various amino acids have been associated with preferential binding affinities with respect to AuNP size and TiO~2~ NP surface charge, supporting a role for multiple physicochemical properties in the molecular initiating event of skin sensitization ([@R263]; [@R439]).

The second validated *in vitro* assay for determination of skin sensitizing potential involves evaluation of the keratinocyte response to test agents, since they are a source of numerous mediators that facilitate LC migration, antigen presentation, and T-cell activation during sensitization ([@R213]). Since many of these mediators are released in response to sensitizer-induced activation of the antioxidant/electrophile sensing pathway Keap1/Nrf2/ARE, its activation is suggestive of potential for the test agent to contribute to the cellular response of the sensitization AOP ([@R327]; [@R328]; [@R389]). The human keratinocyte cell line associated with this assay, HaCaT, has been frequently used to investigate potential metal nanomaterial effects on the skin *in vitro*. Correspondingly, PdNP, AuNP, and PtNP have all been shown to activate the Nrf2 pathway in keratinocytes *in vitro* ([@R129]; [@R484]). Similarly, zinc-containing QD, ZnO NP, and CuO NP have all been shown to alter expression of several specific genes associated with the Nrf2 pathway, including *HMOX1* ([@R396]; [@R398]; [@R240]).

Prior to the establishment of Nrf2 pathway involvement in keratinocyte responses to skin sensitizers, cytokine release by keratinocytes *in vitro* was evaluated as an indicator of sensitizing potential ([@R195]; [@R217]). Tumor necrosis factor (TNF)-α is a keratinocyte-derived cytokine involved in sensitization and is critically involved in skin sensitization by chromium and nickel ([@R256]; [@R504]). Dose-dependent TNFα release has been noted following keratinocyte exposure to AgNP, QD, and ZnO NP, indicating high doses may promote LC maturation and dermal sensitization ([@R408]; [@R398]; [@R186]). IL-18 and IL-1β (cytokines critical for LC activity) have also been shown to be increased by QD, SiO~2~ NP, TiO~2~ NP, and AgNP ([@R405]; [@R408]; [@R527]; [@R398]; [@R154]; [@R538]).

Another mediator involved in skin sensitization that is differentially-released by keratino-cytes in response to irritants and sensitizers is IL-1α ([@R73]; [@R217]). Though it can also be actively secreted after inflammasome activation, IL-1α is an intracellular molecule that functions as an alarmin ([@R13]). During programed cell-death, IL-1α remains associated with chromatin and its sequestration prevents effector functions. Contrarily, under necrotic conditions, it is passively released and bioactive. Accordingly, the mechanism of metal nanomaterial-induced keratinocyte cytotoxicity may significantly impact the development of ACD as a result of differential IL-1α release. Although mechanisms associated the preferential induction of necrosis or apoptosis by nanomaterials have yet to be established, some properties have been correlated to these effects ([@R86]; [@R302]). For example, surface charge of 1.5 nm AuNP was demonstrated to be responsible for the mechanism of cell death in HaCaT cells *in vitro*. Charged AuNP led to disruptions in mitochondrial membrane potential and intracellular calcium levels causing apoptosis, whereas neutral AuNP were associated with necrotic cell death (Schaeub[@R250]). Preferential HaCaT apoptosis or necrosis has also been associated with AgNP surface coating and TiO~2~ NP crystal phase ([@R47]; [@R28]). Collectively, these findings assert that surface chemistry/reactivity of metal nanomaterials may be a critical property in determining whether dermal exposure results in irritation responses or sensitization.

The last validated alternative approach to evaluate skin sensitizing potential involves assessment of the potential for an agent to induce upregulation of activation markers (CD 86 and CD 54) on human APC. However, since the recommended cell lines for these assays (THP-1 and U937) are representative of general DC and not skin-specific DC, these studies will be discussed in the *in vitro* section of this review, as they may also apply to respiratory sensitization and augmentation of allergy.

Very few studies have been conducted to investigate metal nanomaterial effects specific to LC. However, topical exposure to \< 100 nm AgNP in guinea pigs was shown to increase the number of LC at the site of exposure in a dose- and time-dependent manner ([@R218]). This observation is relevant to skin sensitization since the concentration of LC present in the skin has been correlated with increased susceptibility to ACD development. Other *in vivo* studies confirmed metal nanomaterials including QD are taken up by LC and subsequently transported to lymph nodes ([@R184]). *In vitro*, associations with LC have been shown to be influ-enced by SiNP size and surface functionalization ([@R499]; [@R390]). Smaller SiNP size has also been correlated to increased uptake, ROS production, and cytotoxicity to LC *in vitro* ([@R319]; [@R530]).

A specific observation regarding DC that has implications for ACD and dermal sensitization is that some metal nanomaterials can promote DC cross-presentation. Cross-presentation describes uptake of exogenous antigens and their subsequent processing by pathways normally associated with endogenous antigens. As a result, the exogenous antigen is presented by MHC I molecules to CD8^+^ T-cells, generating the cytotoxic effector cells characteristic of ACD.

Aluminum nanoparticles (AlNP), AuNP, FeNP, and SiNP have all been shown to modify DC antigen cross-presentation capacity ([@R39]; [@R246]; [@R153]; [@R189]; [@R199]; [@R311]; [@R98]). The mecha-nism of antigen uptake by DC is known to influence the preferential association of antigens with MHC I or II molecules. Small lipophilic haptens associated with skin sensitization often enter APC via passive diffusion and bind cytoplasmic proteins, favoring their processing by endogenous pathways and presentation by MHC I molecules ([@R403]). Accordingly, passive diffusion through cell membranes similar to that demonstrated by charged 15 nm AuNP may result in promotion of cross-presentation ([@R19]; [@R252]; [@R472]). Contrarily, receptor-mediated endocytosis of larger antigens has been associated with cross-presentation when uptake occurs by F~c~ and mannose receptors ([@R41]). In this regard, the adsorption of macromolecules, including immunoglobulins, to the surface of nanomaterials and physicochemical properties associated with the adsorption of proteins may be critically influential in determining the route of antigen processing.

Another major determinant of antigen association with MHC I or II is persistence inside DC. Antigens resistant to degradation in endosomes are more likely to be processed by MHC I pathways ([@R251]; [@R171]). Likewise, metal nanomaterials with physicochemical properties capable of compromising lysosomal acidification (dissolution rate, surface reactivity) may promote cross-presentation ([@R1]; [@R413]). Similarly, endosomal escape following uptake by DC can result in binding to cytosolic proteins and subsequent perception as an endogenous antigen ([@R251]). One major mechanism of endosomal antigen release leading to cross-presentation is oxidative stress and lipid peroxidation, causing antigen leakage from compromised endosome membranes ([@R442]; [@R436]; [@R94]). Oxidative stress induced by CuNP, FeNP, and TiO~2~ NP have been shown to cause lipid peroxidation, and these metal nanomaterials have also been associated with enhancing DC cross-presentation ([@R456]; [@R325]; [@R279]). Metal nanomaterials have also been associated with the induction of autophagy and production of exosomes by DC, both of which have also been associated with antigen cross-presentation ([@R307]; [@R57]; [@R78]; [@R246]; [@R444]).

Augmentation of existing or developing skin allergy {#S10}
---------------------------------------------------

Since dermal exposure to metal nanomaterials nearly always occurs simultaneously to other exposures, their potential to augment skin allergy has been investigated using various allergy models. Metal nanomaterial effects on skin allergy have been studied with respect to both T-cell-mediated ACD and IgE-mediated atopic dermatitis. The effects of metal nanomaterials in ACD models have demonstrated findings suggestive of potential effects during both allergic sensitization and elicitation. In one study, subcutaneous exposure to TiO~2~NP 1 hr prior to skin sensitization with dinitrochlorobenzene (DNCB) increased susceptibility of mice to sensitization, as evidenced by a lower concentration of DNCB required to induce sensitization ([@R173]; [@R462]). The authors noted that although DNCB is known to induce a T~H~1-dominant response characteristic of ACD, exposure to TiO~2~NP resulted in a T~H~2-dominant response in the regional lymph nodes. In a similar study, TiO~2~NP were applied topically 1 day prior to sensitization with DNCB, and the same effect on sensitization as observed ([@R462]). A diminished T~H~1 response was observed and TiO~2~NP were detectable in the lymph nodes. Contrarily, SiO~2~NP and AgNP did not induce alterations to DNCB sensitizer potency in the same model.

In another study by ([@R183]), a panel of metal nanomaterials with various physicochemical properties was analyzed for effects on chemical-induced ACD both during sensitization and challenge. When mice were sensitized to dinitrofluorobenzene (DNFB), co-administration of QD did not impact the severity of the challenge response to DNFB, irrespective of particle charge. However, QD administration simultaneous to DNFB challenge did impact the allergic response. Moreover, the effect was dependent on the charge of the materials. The negatively-charged particles suppressed inflammation, whereas the positively-charged materials enhanced ear swelling. The authors confirmed that sensitization to QD did not occur and suggested that variations in skin penetrating capacity of the differently-charged materials was responsible for the observed effects. The conclusions regarding a critical role for nanomaterial size and charge on modulation of ACD elicitation responses is supported by other findings, as well. Suppressive effects on allergic elicitation have also been demonstrated following applica-tion of 20 nm SiNP and \<50 nm AgNP-containing cream on ACD reactions to DNFB and 2-deoxyurushiol (Jatana 2017a). Contrarily, exposure to positively-charged functionalized 56 nm SiNP did not augment the severity of oxazolone-induced elicitation responses when topically applied for five consecutive days ([@R345]).

As highlighted by (Jatana 2017a), ACD responses may be subject to modulation as a result of chemical modifications induced by interactions with metal nanomaterials. In their study, the topical application of nanomaterials was subject to removal prior to application of DNFB. As a result, the particle-specific modulation of allergic skin inflammation was not reflective of blocked adduct formation. Although metal nanomaterials exhibit characteristically increased surface reactivity and catalytic potential, their capacity to impact the chemical properties of skin sensitizing chemicals has not been extensively studied. However, a few studies have demonstrated the potential for such effects to impact both ACD sensitization and elicitation. AlNP and AuNP have been shown to act as non-protein carriers of haptens capable of facilitating the generation of hapten-specific adaptive immune responses *in vivo* ([@R178]; [@R281]). Similarly, topical application of ointment containing calcium-based nanoparticles has been shown to capture nickel ions by cation exchange, compromising bioavailability and subsequently preventing the elicitation of nickel-specific ACD ([@R496]).

In addition to ACD, metal nanomaterial effects on IgE-mediated atopic dermatitis have also been examined. Atopic dermatitis is generally associated with protein allergens, which under normal circumstances are not capable of penetrating the skin ([@R461]). However, 100 nm ZnO NP and 5 nm AuNP have been shown to enhance skin penetration by albumin and protein drugs ([@R170]; [@R455]). Likewise, increased permeability of the skin associated with some metal nanomaterials may represent a mechanism by which exposure may increase susceptibility to atopic dermatitis onset.

Simultaneous exposure to TiO~2~ NP, AgNP, and SiO~2~ NP during sensitization to house dust mite (HDM) in atopic dermatitis models has been associated with an amplification of T~H~2 responses. This effect was shown to be more pronounced with decreasing size with respect to AgNP and SiO~2~ NP, but not for TiO~2~ NP ([@R522]; [@R150]; [@R152]). Exposure to 5 nm AgNP during sensitization was associated with an augmentation of mast cell activity that resulted in more severe skin lesions that appeared earlier than those induced by 100 nm AgNP ([@R199] thymic stromal lymphopoeitin (TSLP) and IL-18 production ([@R150]). Decreased particle size has been associated with increased aggravation of atopic dermatitis skin inflammation by nonmetal nanoparticles, as well ([@R523]).

Metal nanomaterial-induced modulation of allergic inflammation in the challenge phase of atopic dermatitis has also been demonstrated. Topical application of both 240 and 20 nm ZnO NP resulted in diminished localized inflammation. However, the smaller particle was associated with more pronounced suppression of local inflammation, but simultaneous increases in systemic production of IgE ([@R177]).

An interesting observation by [@R152] highlights a potentially critical variation between studies that may explain discordant immune effects induced by similar nanomaterials. distinction between allergy model studies that may contribute to discordant findings. The authors demonstrated that, in their study, exacerbation of allergic sensitization was dependent on co-administration of HDM antigen and SiO~2~ NP. When SiO~2~ NP agglomerates were administered at a site distal to that of the allergen, the modulation of antibody production was no longer observed. The dependence of physical associations between nanomaterial and antigen on the subsequent adaptive immune response has been similarly demonstrated by FeNP. In multiple studies, intravenous administration of 58 nm FeNP 1 h prior to subcutaneous ovalbumin (OVA) sensitization resulted in decreased levels of IgG~1~ and IgG~2~ and suppression of T~H~1 and T~H~17 responses in mice ([@R448], [@R446]; [@R167]). Contrarily, when FeNP and OVA were co-administered intravenously or subcutaneously, enhanced antibody responses were seen in mice ([@R380]; Shen I et al. 2018). Similar immune-stimulating effects of FeNP have been demonstrated when used as an adjuvant by various exposure routes during immunization to various other antigens in the context of vaccine studies ([@R383]; [@R155]; [@R467]; [@R330]; [@R540]).

The capacity for the same metal nanomaterial to induce divergent immune effects depending on its physical association with antigen likely reflect the different mechanisms of immune modulation associated with prototypical vaccine adjuvants. Some adjuvants exert effects based on "immune modulating" mechanisms. These adjuvants often bear structural resemblance to PAMP, which emphasizes their similar mechanisms of innate immune activation that promote antigen-specific adaptive responses. Since these adjuvants alter the systemic immune environment, their effects are not dependent on physical association with the antigen ([@R458]). Contrarily, physical association with antigen is required for adjuvants whose efficacy reflects their capacity to modulate antigen delivery to the immune system. The strength and nature of the adaptive immune response are heavily dependent on the dose and duration of antigen exposure to lymphocytes, so many adjuvants enhance adaptive immune responses by augmenting this process ([@R190]).

In accordance with these two divergent mechanisms of sensitization adjuvancy, different physicochemical properties of metal nanomaterials may be implicated in immune effects resulting from each mode of action. For example, simultaneous administration of adjuvant and antigen is often implemented with the intent of depot formation, which increases local antigen retention ([@R127]; [@R89]). Accordingly, metal nanomaterial adjuvant effects dependent on this mechanism are subject to influence by properties involved in antigen trapping, such as size, degree of agglomeration, surface area, and surface charge ([@R147]; [@R148]; [@R203], [@R204]).

Knowledge gaps in metal nanomaterial effects on skin allergy {#S11}
------------------------------------------------------------

Knowledge regarding metal nanomaterial effects on skin sensitization is largely limited to TiO~2~ NP, SiO~2~ NP, and ZnO NP. Though the selective investigation of these metals is likely reflective of their significance to consumer skin exposures, titanium, silver, and zinc are not historically associated with clinically-significant rates of ACD in the general population. Accordingly, the observation that some of these metals may have increased potential to induce skin sensitization in nanoparticulate form raises additional concerns over the lack of investigations into nanomaterials comprised of metals commonly associated with ACD (nickel, gold, cobalt).

Metal-based nanomaterials and asthma {#S12}
====================================

Respiratory exposure to nanomaterials from naturally-occurring and anthropogenic sources has been taking place for centuries; however, the emergence of engineered nanomaterials and their widespread incorporation into consumer goods pose a risk for inhalation exposures to higher doses of materials with diverse chemical compositions and unique properties ([@R50]). In this regard, metal nanomaterials of concern for consumers include many of the materials mentioned above, such as ZnO NP, AgNP, TiO~2~ NP, and SiO~2~ NP, as a result of their incorporation into construction materials, sunscreen sprays, disinfectants, and cosmetic powders, which upon use can lead to their inhalation. Workers are at risk for inhalation exposure to these and other highly-produced metal-based nanomaterials ([Table 1](#T1){ref-type="table"}) (Nanomaterials Future Markets 2015). Effects of metal nanomaterials on pulmonary immunity and asthmatic conditions have been extensively studied and summarized in this section. In addition to studies reporting adverse immune effects in workers subject to metal nanomaterial inhalation, animal studies that have generated evidence of potential for respiratory sensitization and augmentation of asthmatic conditions are discussed. Likewise, [Table 5](#T5){ref-type="table"} summarizes studies characterizing individual metal nanomaterial effects on pulmonary immunity. [Table 6](#T7){ref-type="table"} summarizes studies to examine the effects of metal nanomaterial physicochemical properties on asthma. [Table 7](#T7){ref-type="table"} highlights some processes involved in respiratory sensitization and elicitation demonstrated to be subject to modulation by metal nanomaterials.

Human studies demonstrating pulmonary immune effects of metal nanomaterials {#S13}
---------------------------------------------------------------------------

A 2014 case study best illustrates the concerns associated with the unknown allergic effects of metal nanomaterials. In the report, a chemist who accidentally inhaled NiNP in the work-place subsequently developed clinical symptoms indicative of IgE-mediated respiratory allergy including throat irritation, nasal congestion, facial flushing, and respiratory distress upon future encounters with NiNP. The chemist also developed previously-nonexistent symptoms indicative of T-cell-mediated ACD in response to non-nanoparticulate forms of nickel in her earrings and belt buckles ([@R194]). In addition to reinforcing existing concerns over increased potential for allergic sensitization as a result of decreased size, the case also emphasized additional concerns reflective of the unique mechanisms of metal allergy. The case showed that sensitization via one exposure route may not limit future elicitation reactions to the same tissue; moreover, sensitization by metal ions, irrespective of original parent material size, may result in elicitation reactions following exposure to both nano- and bulk-sized metal materials.

Adverse immune effects with implications for allergy have been investigated in human subjects with risk of inhalation exposure to metal nanomaterials in their workplaces. In one study, it was shown that workers of nanomaterial-handling facilities in Taiwan exhibited increased prevalence of sneezing, dry cough, and productive cough compared to workers with no nanomaterial exposures ([@R249]). Although the workers were employed by facilities handling SiO~2~ NP, Fe~2~O~3~ NP, AuNP, AgNP, and TiO~2~NP, it is unclear whether the observed respiratory effects were mediated by adaptive immune responses specific to the metals, or nonspecific irritant mechanisms. Interestingly, increased rates of ACD were also observed in the workers of the nanomaterial-handling facilities, but the inciting agents were not determined. As such, it is unknown if exposure to the nanomaterials induced sensitization or caused increased susceptibility to ACD development in workers.

Similar studies have also demonstrated that exposure to nanomaterials in the workplace can cause elevations in various immune-related biomarkers indicative of potential effects on allergy ([@R12]; [@R126]; [@R222]) For example, elevations in breath condensate leukotriene (LT) levels were observed in subjects exposed to TiO~2~ NP aerosol (\< 100 nm) in their workplaces ([@R79]). The exposed workers had elevated levels of LTB~4~, a lipid mediator associated with the recruitment, activation, and prolongation of survival of leukocytes in the lung, as well as multiple cysteinyl leukotrienes (i.e. LTC~4~, LTE~4~, LTD~4~), that are potent mediators of bronchoconstriction ([@R267]; [@R534]). Although no alterations in lung function were observed in the exposed workers, elevations in levels of lipid mediators involved in the pathogenesis of asthma suggest the potential for exposure to TiO~2~NP in the workplace to influence the severity of asthmatic conditions.

Collectively, these reports emphasize the potential occupational hazards associated with metal nanomaterials. Although numerous immune markers have been shown to be modulated in workers following inhalation exposure to metal nanomaterials, specific implications for asthma remain unclear. Limitations of human studies arise from inconsistencies between exposure conditions, subject histories, and the requirement for noninvasive, measurable endpoints. Accordingly, the effects of metal nanomaterials on pulmonary immunity and underlying mechanisms have been assessed in animal models wherein controlled dosing, consistent environments, and additional endpoints have helped identify some of the potential underlying mechanisms of metal nanomaterial-induced pulmonary immune effects.

Evidence for increased potential for respiratory sensitization from animal studies {#S14}
----------------------------------------------------------------------------------

Assessment of respiratory sensitization presents numerous challenges underscored by the absence of validated *in vivo*, *in vitro*, or *in silico* approaches for identification of potential sensitizers. However, biomarkers with proposed utility for *in vivo* identification of potential respiratory sensitizers following pulmonary exposure include IgE and T~H~2 cytokines ([@R83]; [@R58]). These markers have not been employed for direct evaluation of respiratory sensitization potential by metal nanomaterials; however, numerous studies have reported increased IgE levels following *in vivo* pulmonary exposure to TiO~2~ NP, PtNP, FeNP, AgNP, and ZnO NP ([@R359]; [@R360]; [@R354]; [@R168]; [@R432]). Many of the same nanomaterials have also been associated with increased T~H~2 cytokine levels (i.e. IL-4, IL-5, IL-13) following pulmonary exposure ([@R373]; Park 2010; [@R285]). Although these findings are suggestive of the potential for metal nanomaterials to induce asthma, since the specificity of IgE molecules was not determined in any studies, the capacity for respiratory sensitization remains speculative.

Assessment of respiratory sensitization potential is further complicated by the absence of an AOP specific to the events associated with asthma development. Moreover, discrepancies in some key events involved in asthma inception by LMW and HMW agents indicate the potential requirement for multiple respiratory sensitization AOP. However, many steps are known to be conserved with respect to sensitization of the skin and lungs; knowledge of metal nanomaterial effects on these processes can provide potential insight regarding their potential to cause asthma.

The induction of respiratory sensitization is ultimately dependent on antigen bioavailability. Although it remains unclear whether nano-scale dimensions of metals increase the likelihood for absorption following dermal exposures, the respiratory tract presents a portal of entry known to be increasingly susceptible to smaller materials ([@R295]). Nano-materials exhibit a characteristically increased level of "dustiness," a property which describes the propensity for a material to become airborne following disruption ([@R104]). Accordingly, the potential for aerosolization and inhalation of metal nanoparticles increases with decreasing size, thereby overcoming one of the limiting steps of respiratory sensitization associated with larger-sized metal particles.

Sensitization of the lungs also requires interactions between the sensitizing agent and APC. The respiratory tract is equipped with an expansive repertoire of defense mechanisms that prevent such interactions, but metal nanomaterials have been shown to have increased capacity to circumvent many of these mechanisms, increasing their potential for uptake by DC. In the upper airways, a layer of mucus lining the lumen functions to trap inhaled antigens and facilitate their translocation out of the trachea by the mucociliary escalator ([@R304]). Evasion of the \~5 mm thick mucus layer has been associated with nanomaterial physicochemical properties including size, surface modification, and surface charge ([@R409]; [@R524]; [@R261]; [@R316]). Generally, hydrophilic, neutrally-charged nanomaterials with smaller diameters have been shown to penetrate mucus to a greater degree than counterparts with opposing properties ([@R429]).

In the lower airways, a similar mechanism of antigen neutralization is facilitated by pulmonary surfactant ([@R67]). In addition to optimizing the mechanics of respiration, surfactant contains proteins capable of binding aeroallergens, accelerating their clearance, and preventing their uptake by APC, thereby inhibiting antigen-specific responses ([@R275]; [@R503]; [@R156]; [@R402]). Two of these proteins, surfactant protein (SP)-A and SP-D, have been shown to bind to various metal nanomaterials leading to accelerated clearance by phagocytic mechanisms ([@R402]). Accordingly, nanomaterials with properties that deter binding to surfactant proteins, such as surface charge, may exhibit increased potential for evasion of clearance by this mechanism, increasing potential for interaction with lung DC ([@R428]).

Increased potential for antigen/nanomaterial interaction with DC can also result from evasion of pulmonary macrophage-mediated clearance. Uptake and sequestration of antigen by pulmonary macrophages results in intracellular chemical degradation or physical translocation out of the lungs, preventing their interception by DC (Elder and Oberdörster 2006). Nano-materials can evade clearance by this mechanism by numerous effects. First, since macrophages have been shown to selectively phagocytose nanomaterials according to size, charge, and surface modification, physicochemical properties may contribute to their persistence in the respiratory tract. Their clearance may also be compromised as a result of selective cytotoxic effects on pulmonary macrophages and subsequently fewer viable macrophages capable of neutralizing the nanoparticles. Pulmonary macrophage cytotoxicity has been associated with physicochemical properties including morphology, surface charge, and rate of dissolution ([@R339]; [@R141]; [@R450]). Metal nanomaterial-induced alterations in phagocytic activity of pulmonary macrophages, as demonstrated by TiO~2~ NP, ZnO NP, and AlNP, may also contribute to evasion of clearance ([@R501]; [@R260]; [@R259]). In addition to compromising the clearance capacity of the phagocytic system on a cellular level, nanomaterials are also associated with maximizing the clearance capacity of the collective phagocytic system. Volumetric loading of alveolar macrophages following inhalation of nanomaterials decreases the efficiency of clearance, extending biopersistence, and increasing the potential for interception by DC ([@R336]; [@R40]).

Metal nanomaterial cytotoxic effects on pulmonary macrophages may also promote sensitization by additional mechanisms. Since alveolar macrophages are known to antagonize T~H~2 responses in the lung and downregulate APC functions, cytotoxic effects may disrupt the maintenance of an immunological tolerant state ([@R471]). Moreover, their depletion leads to significantly increased recruitment of DC and DC precursors to the lungs ([@R161]; [@R180]). Numerous metal nanomaterials are also known to trigger the release of alarmins including IL-1β and −1α by alveolar macrophages; in turn, these can activate DC and facilitate sensitization ([@R48]; [@R418]; [@R410]; [@R141]; [@R384]; [@R15]).

Similar to their roles in the development of skin allergy, epithelial cells of the respiratory tract are integral in the development of asthma, and their disruption by inhaled materials can have profound influence on the early events of sensitization ([@R33]). A major function of airway epithelial cells is to serve as a physical barrier between inhaled agents that deposit in the airway lumen and DC in the epithelium ([@R142]). The importance of barrier integrity in preventing the development of asthma is illustrated by the barrier-disrupting proteolytic activity shared by many aeroallergens with high rates of sensitivity in the population ([@R202]; [@R230]). The frequent observation that metal nanomaterials are capable of inducing cytotoxicity to pulmonary epithelial cells suggests their potential to increase permeability and passage of antigens from the airway lumen to compartments associated with DC.

Airway epithelial cell cytotoxicity has also been associated with the release of alarmins that have potential to promote DC activation and sensitization. Similar to keratinocytes in the skin, the mechanism of cell death can critically influence the nature of the resultant immune response. For example, the necrotic cell death following pulmonary exposure to beryllium results in the release of mediators including cellular DNA, which is recognized as a DAMP by TLR-9, and promotes the unique T~H~1-mediated effects associated with chronic beryllium disease ([@R293]). NiNP, AgNP, and CoNP have been shown to induce similar necrotic cell death of bronchial and alveolar epithelial cells ([@R161]; [@R500]; [@R82]; [@R53]; [@R343]). Contrarily, ZnO NP, CuO NP, TiO~2~ NP, and CrNP have all been associated with induction of apoptotic cell death in pulmonary epithelial cells ([@R355], [@R357]; [@R3]; [@R466]; [@R434]). This effect may further influence the development of respiratory allergy since uptake of these cells is a property exclusive to CD103^+^ DC, a subset of DC associated with cross-presentation and the subsequent induction of CD8^+^effector responses ([@R90]).

Incorporation of metal nanomaterials into asthma models {#S15}
-------------------------------------------------------

The impact of metal nano-material exposure prior to sensitization has only been addressed by a few studies using asthma models. Aspiration exposure to ZnO NP, TiO~2~ NP, NiO NP, CuO NP, or SiO~2~ NP 1 d before inhalation sensitization to OVA was followed by inhalation challenge and subsequent assessment of asthmatic severity. Soluble metal nanomaterials (NiO NP, ZnO NP, and CuO NP) were associated with elevations in OVA-specific IgE, whereas insoluble SiO~2~ NP and TiO~2~ NP were not. Subsequent investigations confirmed the importance of metal ion release in the adjuvant effects on sensitization. The increase in OVA-specific IgE production associated with soluble NiO NP was not conserved in response to insoluble NiO microparticles in the same model ([@R163]). However, ZnCl~2~ also did not exert the same increase in OVA-specific IgE caused by ZnO NP. As a result, it was concluded that continuous ion release from nanoparticles was required for the induction of the observed effects ([@R164]). Exposure to residual oil fly ash particles prior to allergen sensitization has also been associated with adjuvant effects attributable to soluble metal constituents ([@R229]).

Concurrent exposure to metal nanomaterials during allergen sensitization has been explored extensively in order to evaluate the potential adjuvant effects of metal nanomaterials on asthma development. This concept has been explored with respect to both systemic and respiratory sensitization routes, as well as independent and dependent of allergen challenge. In the absence of allergen challenge, evaluation of sensitization achieved by intraperitoneal injection is limited to assessment by systemic markers, such as antigen-specific IgE and cytokine levels. Accordingly, co-administration of AgNP and ZnO NP with antigen has been associated with elevated levels of allergen-specific IgE, as well as increased levels of T~H~2 cytokines ([@R286]; [@R517]). As demonstrated with SiO~2~ NP, enhanced antibody production has been associated with both increasing dose and decreasing particle size ([@R478]).

Though few studies have correlated metal nanomaterial properties to adjuvant effects on intraperitoneal sensitization independent of allergen challenge, existing findings are conducive with studies using larger metal particles and nonmetal nanoparticles ([@R322]; [@R135]). The impact of the most extensive number of physicochemical properties with respect to adjuvant effects on OVA sensitization use polystyrene nanoparticles (PSP). [@R335] used PSP ranging from 58 nm to 11.4 μm to evaluate the influence of particle size, mass, surface area, and particle number. Similarly, Granum et al. (2000) used six sizes of spherical PSP to administer doses with constant mass (12.25 μg), size (0.1 μm), particle number (8 × 10^10^), or surface area (1300 cm^2^). Both studies showed that serum OVA-specific IgE levels best correlated with particle number and surface area ([@R134]; [@R335]).

Similar adjuvant effects have been observed following respiratory sensitization and co-exposure to TiO~2~ NP, SiO~2~ NP, and ZnO NP ([@R81]; [@R168]). Increases in OVA-specific IgE and T~H~2 cytokine levels were similarly associated with decreasing size of SiO~2~ NP ([@R531]). Moreover, SiO~2~NP surface properties were shown to impact sensitization independent of allergen challenge. Intranasal exposure to three variations of SiO~2~ NP (spherical, mesoporous, and PEGylated) simultaneous to OVA sensitization exacerbated pathological changes, inflammatory cell influx, and T~H~2 cytokine responses. These effects were specific to the unique surface chemistry of each type of SiO~2~ NP, but the most severe responses were associated with the nanoparticle with the highest surface area ([@R144]).

The absence of allergen challenge in these studies helps elucidate the direct effects of metal nanomaterials on sensitization processes. However, another approach to evaluate the same effect involves evaluation of allergic parameters collected in response to allergen challenge. Studies utilizing this approach have similarly demonstrated enhanced asthmatic responses in OVA-challenged mice when intraperitoneal sensitization occurred simultaneous to TiO~2~ NP and ZnO NP ([@R236]; [@R400]; [@R400]; [@R297]).

Although the observed effects may reflect residual impacts of metal nanomaterial respiratory exposure during sensitization, similar adjuvant effects on elicitation responses have been observed following respiratory sensitization and simultaneous metal nanomaterial exposure. Simultaneous administration of SiO~2~NP, CeO~2~NP, QD, and TiO~2~NP with allergen during sensitization led to enhanced asthmatic response severity, as measured by antigen-specific antibody levels, inflammatory cell influx, and T~H~2 cytokine levels after challenge ([@R46]; [@R294]; [@R495]; [@R431]). Studies using similar sensitization procedures and endpoints have also implicated TiO~2~ NP crystal structure in adjuvant effects on sensitization ([@R81]; [@R495]).

Metal nanomaterial exposure has also been incorporated into the challenge phase of asthma to evaluate potential modulation of asthmatic responses in established asthmatic conditions. Although some metals, including CuO NP, have been exclusively shown to induce significant aggravating effects on elicitation responses, others, including AuNP, appear to exert protective effects on asthmatic responses ([@R26]; [@R356]; [@R340]). Contrarily, other metal nanomaterials, including TiO~2~ NP, have been associated with divergent effects on allergen challenge that appear increasingly susceptible to variation during this phase of asthma. Effects have been reported to be differentially induced according to dose, duration of exposure, and endpoints of assessment ([@R399]; [@R174]; [@R192]; [@R210]).

Similarly, after OVA sensitization via intraperitoneal injection, AgNP exposure during allergen challenge has been reported to induce various aggravating and attenuating effects on allergic inflammation. Inhalation exposure to 6 nm AgNP was shown in multiple studies to suppress inflammatory cell influx, airway hyper-reactivity (AHR), mucus hypersecretion, and other measures of asthmatic responses (Park, Kim, Jang, et al. 2010; [@R181]). Contrarily, in another study with very similar exposure conditions, 33 nm AgNP caused increased airway response, inflammatory cell influx, and OVA-IgE levels over control animals ([@R69]; [@R465]). The discrepancies between these studies may be attributable to AgNP size difference, as well as potential variations in particle coating, both of which have been associated with differ-ential effects on asthmatic responses ([@R6]). Additionally, the first two studies used the T~H~1-dominant C57BL/6 mouse strain, whereas the second used a T~H~2-biased BALB/c strain ([@R193]). Strain-specific immune responses following respiratory exposure to metal nanomaterials during allergen challenge have been demonstrated in other studies, as well ([@R139]).

Studies using SiNP and ZrO NP with variations in surface properties demonstrate that when administered during allergen challenge, surface properties of nanomaterials can differen-tially aggravate allergic inflammation ([@R285]; Park, Sohn, et al. 2015; [@R497]). It has been suggested that particles with higher oxidant potential amplify asthmatic inflammation to a greater degree, which would implicate physicochemical properties such as surface modification in these effects ([@R247]).

Potential mechanisms of asthma augmentation by metal nanomaterials {#S16}
------------------------------------------------------------------

Although asthma models have characterized the potential effects of metal nanomaterial exposure on asthmatic processes, many of the underlying mechanisms of these observed effects remain unclear. However, findings from other studies suggest several mechanisms may be associated with the observed effects of metal nanomaterials on the augmentation of asthma.

Respiratory exposure to metal nanomaterials may increase susceptibility to sensitization by aeroallergens by similar mechanisms previously proposed to contribute to their respiratory sensitization potential. Release of alarmins by airway epithelial cells and resident immune cells, disruption of the T~H~1/T~H~2 balance in the lung, and amplification of oxidative stress by metal nanomaterials may also generate adjuvant effects on sensitization. Similarly, FeNP, TiO~2~ NP, and SiNP have all been shown induce the release of T~H~2 cytokines including IL-33, TSLP, GM-CSF, and IL-25 by airway epithelial cells, which are known to promote DC maturation ([@R172]; [@R490]; [@R280]; Park, Sohn, et al. 2015).

Evidence also suggests metal nanomaterial exposure can modulate inflammatory pheno-types of existing asthmatic conditions. Two major heterogeneous asthma phenotypes differ based on the presence of neutrophil (T~H~1/T~H~17)- or eosinophil (T~H~2)-dominated inflammation ([@R106]; [@R533]). Particulate and soluble metals are known to differentially impact the nature of existing allergic airway inflammation by skewing this balance ([@R423]). Dissolution kinetics also appear influential in this regard, as CoNP, NiNP, ZnO NP, and CuO NP and their corresponding ions have been shown to differentially recruit eosinophils and neutrophils to the lungs of rats after exposure ([@R65]; [@R185]).

Modulation of elicitation response severity by metal nanomaterials may emerge as a result of modulation of mast cell activity. As a major effector cell in IgE-mediated allergic responses, mast cells have been shown to be potential targets of metal nanomaterial-induced adverse effects *in vitro* ([@R110]; [@R191]; [@R8]). AgNP, CuO NP, SiO~2~ NP, and TiO~2~ NP have all been shown to induce IgE-independent mast cell degranulation depending on physicochemical properties including size, surface area, charge, shape, and the presence of adsorbed surface proteins ([@R282]; [@R5]; [@R7]; [@R191]). Modulation of IgE-dependent mast cell degranulation has also been demonstrated by some of the same nanomaterials. TiO~2~ NP, AuNP, CeO~2~ NP, ZnO NP, and FeNP have been shown to modulate interactions between allergen and surface-bound IgE molecules, interfering with dimerization and subsequent degranulation ([@R169]; [@R342]). Similarly, mast cell uptake of metal nanomaterials has been associated with modulation of intracellular calcium signaling involved in mast cell degranulation ([@R10]; [@R61]). Accordingly, differential ion release by bulk ZnO particles, ZnO NP, and soluble ZnSO~4~ has been correlated with the propensity for OVA-sensitized rat mast cells to degranulate when co-exposed with OVA ([@R520]; [@R110]).

Furthermore, TiO~2~ NP and AuNP have been shown to alter the exocytic kinetics of granule secretion by mast cells ([@R283]). The qualitative and quantitative profile of granule contents has also been shown to be subject to modulation by some metal nanomaterials. The number of molecules per granule has been shown to be impacted by SiO~2~ NP as a function of porosity and surface area ([@R290]). Variations in vesicle mediator content has been shown to be augmented by AuNP ([@R283]). Since the contents of mast cell granules contribute to vascular permeability and inflammatory cell recruitment, these alterations can greatly impact the severity of allergic elicitation ([@R99]; [@R508]).

Aggravation of existing asthmatic conditions may also involve non-immunological mechanisms, such as metal nanomaterial-induced alterations to normal physiological processes. For example, increased mucus production by epithelial cells is a hallmark symptom of the early and late phase asthmatic response ([@R103]). The observation that TiO~2~NP and CuONP both increased mucin secretion in human epithelial cells suggests potential to exacerbate asthmatic conditions by contributing to obstruction of airways ([@R60]; [@R356]). Similarly, TiO~2~ NP, AuNP, and AgNP have been shown interfere with optimal pulmonary surfactant functioning, which can cause AHR and increased resistance to airflow ([@R157]; [@R156]; [@R23]; [@R419]; [@R536]). AHR may also be modulated by metal nanomaterials as a result of alteration of airway smooth muscle (ASM) contractility. ZnO NP, CuO NP, and TiO~2~ NP have all been shown to alter human ASM mechanical function *in vitro* ([@R35]). Similarly, CoFe~2~O~4~ NP were shown to potentiate both histaminergic and cholinergic ASM contractility *in vivo*, which has the capacity to exacerbate symptoms of asthma associated with bronchoconstriction ([@R200]).

Metal nanomaterial exposure may also exacerbate established asthmatic conditions by accelerating the progression of pathological alterations associated with chronic asthmatic conditions. The repetitive induction and resolution of inflammation induced by asthmatic elicitation leads to anatomical alterations referred to as airway remodeling ([@R109]). Histological indicators of these alterations have been reported to be exacerbated by various metal nanomaterials including SiNP ([@R143]). Similarly, cellular indicators of accelerated airway remodeling have been implicated in response to many metal nanomaterials. For example, fibroblast accumulation and increased extracellular matrix deposition is a common contributor to airway remodeling and has been observed in response to NiNP, SiO~2~ NP, and CeO~2~ NP exposure ([@R506]; [@R143]; [@R269]; [@R16]; [@R128]).

Knowledge gaps in metal nanomaterial effects on asthma {#S17}
------------------------------------------------------

Despite the known capacity for many metals to induce IgE-mediated asthma following inhalation, the potential for metal nanomaterials to induce sensitization of the respiratory tract remains completely unknown. Several other interesting aspects of pulmonary immunity have not been widely addressed with respect to metal nanomaterials, and may have relevance to current observations regarding their effects on asthma. The microbiome is known to significantly impact numerous aspects of allergic disorders, and while some metal nanomaterials associated with antimicrobial activity have been shown to alter the pulmonary microbiome, the implications for asthma remain unknown ([@R6]; [@R378]). Similarly, the effects of metal nanomaterials on innate lymphoid cells also remain largely unstudied, but should not continue to be neglected, given the importance of this cell type in allergic disorders. Finally, the capacity for metal nanomaterials to disrupt or prevent the development of immunological tolerance has not been explored, and may be influential in both phases of asthmatic conditions.

Effects of metal nanomaterials on immune cells and allergic processes *in vitro* {#S18}
================================================================================

*In vivo* studies have demonstrated the capacity for metal nanomaterials to augment numerous immunological processes that result in functional implications for allergic disease. However, *in vitro* investigations have helped elucidate some of the underlying mechanisms responsible for *in vivo* observations. In this section, major findings regarding the role of metal nanomaterial physicochemical properties on molecular and cellular processes with implications for both ACD and asthma are summarized.

Effects on antigen immunogenicity {#S19}
---------------------------------

Many physicochemical properties associated with the molecular and cellular processes that confer antigen immunogenicity are subject to alteration following interactions with constituents of their environment. In this regard, the immunogenicity of metal nanomaterials may be significantly altered as a result of biocorona formation. Following entry into biological media, macromolecules present in the media interact with and adsorb to the surface of nanomaterials within minutes, forming a layer that defines the bio-identity of the nanomaterial ([@R74]). The qualitative profile of adsorbed constituents and quantitative strength of association have been shown to be influenced by nanomaterial properties including size, charge, morphology, surface modification, and hydrophilicity, among other properties ([@R265]; [@R96]).

Independent of adsorbed constituents' identities, macromolecule associations with metal nanomaterial surfaces may induce alterations in physicochemical properties associated with their bioactivity (Dobrovolskai et al. 2009b; [@R528]). For example, protein adsorption to 25 nm FeNP was associated with a 5-fold increase in hydrodynamic size, which can impact a number of biological effects, such as propensity for cellular uptake ([@R52]). Similarly, adsorption of proteins can mask reactive surfaces of metal nanomaterials, attenuating ROS generation, and subsequently inhibiting a major biochemical mechanism involved in the release of alarmins ([@R176]).

Contrarily, surface adsorption of macromolecules may alter the biological activity of metal nanomaterials in a manner that is dependent on the adsorbed constituent profile. Endo-genous proteins, including immunoglobulins, cytokines, and complement proteins are all constituents of the serum and lung lining fluid known to bind metal nanomaterial surfaces ([@R329]). The binding of complement protein C3b and IgG to nanomaterial surfaces has been shown to confer recognition by complement and Fc receptors, accelerating clearance by phagocytes, and limiting the potential of the nanomaterial to induce other immune effects ([@R29]; [@R300]; [@R116]). Adsorption of exogenous agents can also lead to alterations in nanomaterial immunogenicity. One of the most notable examples is endotoxin (LPS), a frequent microbial contaminant of nanomaterial surfaces that is capable of activating innate immune cells, and inducing pro-inflammatory signaling via the TLR-4 pathway. Adsorption of LPS to nanomaterial surfaces has been shown to enhance inflammatory responses to many metal nanomaterials by lung epithelial cells, and various immune cells ([@R449]; [@R258]; [@R36]; [@R248]; [@R216]). The chemical structure of LPS favors its adsorption to hydrophobic, positively-charged metal nanomaterial surfaces, indicating a role for physicochemical properties such as surface modification in the propensity for associations with immunogenic exogenous molecules such as LPS ([@R133]; [@R248]).

Although biocorona formation can augment the immunological fate of a nanomaterial, the interactions may also facilitate alterations in immunogenicity of the adsorbed constituents. Deng et al. (2010) showed that functionalized AuNP were capable of binding fibrinogen independent of nanoparticle size, but certain sizes of AuNP induced conformational changes in the protein. Subsequent alterations in protein structure conferred its recognition by the Mac-1 receptor, subsequently activating NF-κB signaling in innate immune cells. Similarly, Bastus et al. (2009) demonstrated that while macrophages did not recognize AuNP or two biomedically-relevant peptides individually, their conjugation facilitated recognition by TLR-4 and the subsequent induction of pro-inflammatory cytokine production. Since these signaling pathways play critical roles in many of the adjuvant effects mentioned in previous sections, interactions between metal nanomaterials and host proteins can generate novel sources of immunogenicity that may promote allergic processes.

The generation of metal antigens *in vitro* has been shown to be impacted by the unique physicochemical properties of metal nanomaterials. The size-specific increase in surface energy of TiO~2~ NP was shown to promote associations between the metal and human serum albumin, resulting in increased bioavailability ([@R492]). This altered propensity for inter-actions with host proteins contributed to the observation that titanium antigens generated from ionic and nanoparticulate forms of TiO~2~ induced differential proliferation of CD4^+^ and CD8^+^ T-lymphocytes *in vitro* ([@R158]).

Effects on processes involved in sensitization {#S20}
----------------------------------------------

As the primary APC involved in allergic sensitization, the capacity for metal nanomaterials to modulate DC activity represents a prominent mechanism by which allergic sensitization can be impacted ([@R187]). Since many sensitizing agents are known to induce both antigen-specific and nonspecific signals to DC following exposure, DC activation is a step of the dermal sensitization AOP used for *in vitro* identification of potential sensitizers. Accordingly, the h-CLAT method has been validated for use by the OECD to determine the skin sensitizing potential of agents. In this assay, undiffer-entiated THP-1 human monocytic leukemia cells are exposed to an agent for 24 h and their activation status is subsequently assessed by quantification of CD86 and CD54 activation marker expression ([@R20], [@R21]; [@R334]).

The h-CLAT assay has not been employed to evaluate the sensitizing potential of any metal nanomaterials; however, several studies have investigated metal nanomaterial effects on undifferentiated THP-1 cells following a 24-h exposure, and reported activation marker expression. Accordingly, up-regulation of CD86 expression was observed following exposure to surface-modified FeNP, SiO~2~ NP, and mixed-metal alloy nanoparticles (Liu, Y et al. 2013). [@R84] exposed THP-1 cells to a wide range of SiO~2~ particle sizes (10--1430 nm); while all particles promoted activation marker expression, the 240 nm SiO~2~ particles induced the greatest degree of CD80 expression. Similar findings were reported by an investigation that assessed the potential for metal debris released from orthopedic implants to trigger immune activation. Both \~2 mm cobalt-chromium-molybdenum alloy particles and soluble metal ions induced elevations in THP-1 co-stimulatory molecule expression, suggesting that a wide range of metal particle sizes have the capacity to induce immune effects involved in allergic sensitization ([@R51]; [@R84]). Contrarily, no elevations in THP-1 expression of CD86 or CD54 were observed in response to 100 nm AgNP exposure ([@R117]).

Though CD86 and CD54 are the validated biomarkers indicative of sensitizing potential in the THP-1 line, limited reports have evaluated these specific markers following metal nanomaterial exposure. However, other markers indicative of DC activation, such as MHC II, CD11b, CD14, CCR2, and CCR5 have been reported to be up-regulated in response to exposures to ZnO NP and FeNP ([@R381]; [@R289]). Similarly, modulation in expression of 60 genes -- several of which were correlated to monocyte differentiation and maturation -- were observed in response to PtNP exposure ([@R120]).

The THP-1 cell line has also been used to identify potential skin sensitizers *in vitro* based on a unifying property of rapid ROS production following exposure to skin sensitizing chemicals ([@R298]). A similar response has been demonstrated in the cell line following exposure to \< 100 nm silver-copper alloy nanoparticles, AgNP, CoO NP, PdNP, and NiNP ([@R305]). The degree of ROS production by THP-1 cells has been correlated to properties including particle size and corona presence, as well as exposure dose and duration ([@R115]; [@R54]; [@R331]). Subsequent activation of the p38 MAPK signaling pathway, alterations in expression of *HMOX1* and other oxidative stress genes have also been used as *in vitro* biomarkers suggestive of sensitizing potential. Numerous metal nanomaterials have been associated with these effects on THP-1 cells, which suggests their potential to activate DC and promote sensitization ([@R301]; [@R207]; [@R292]; [@R42]).

The potential for metal nanomaterials to induce DC activation has been more extensively examined using primary DC than the cell lines used in the validated assays ([@R198]). Although the expression of activation markers in murine bone marrow-derived DC (BMDC) or human monocyte-derived DC (MDDC) has not been validated by OECD for use in determining sensitization potential *in vitro*, several studies have reported their capacity to accurately predict sensitizers ([@R489]; [@R367]). Accordingly, TiO~2~ NP, ZnO NP, and SiO~2~ NP have been associated with increased expression of CD80 and CD86 by murine BMDC with respect to size, surface chemistry, and crystallinity ([@R349] [@R146]; [@R511]; [@R542]; [@R510]; [@R495]).

Nanomaterial-induced modulated DC activity can also influence sensitization indepen-dent of their capacity to induce phenotypical maturation. For example, uptake of AuNP and AgNP resulted in an enhanced capacity for DC maturation in response to other immune stimuli ([@R341]). This finding suggests uptake of antigens normally incapable of activating DC may trigger their maturation in the presence of nanomaterials. In addition, accumulation of metal nanomaterials has been proposed to interfere with antigen processing and presentation by DC ([@R474]; [@R171]).

Polarization of DC and the subsequent preferential generation of T~H~1/T~H~2 effector T-cells is another step in the development of allergy that has been shown to be susceptible to modulation by nanomaterials. Dermal and respiratory sensitizers are associated with divergent oxidative stress responses that induce selective alterations in three major signaling pathways responsible for DC polarization ([@R299]; [@R14]). Polarization of DC towards T~H~1-promoting activity has been associated with the propensity for skin sensitizers to react with cytoplasmic glutathione following which, rapid depletion leads to ROS accumulation. The rapid induction of oxidative stress induced by contact sensitizers is responsible for the selective activation of the p38 MAPK and JNK signaling pathways within minutes of encounter ([@R323]). Contrarily, polarization of DC towards T~H~2-dominant responses has been associated with delayed induction of oxidative stress resulting from the preferential association of respiratory sensitizers with intracellular amine groups ([@R112]). Subsequently, selective activation of the NF-κB and ERK pathways occurs.

Knowledge of these pathways and their differential activation explain the observation that metal nanomaterials with opposing catalytic properties induce different polarization profiles in DC *in vitro*. The oxidant capacity of TiO~2~ NP resulted in potentiation of DC maturation leading to a T~H~1-biased responses, whereas treatment with the anti-oxidant surface activity of CeO~2~ NP resulted in secretion of anti-inflammatory IL-10 and a T~H~2-dominant T-cell profile ([@R415]). FeNP, AuNP, and GdNP have also been associated with modulation of DC polarization *in vitro* with respect to size and surface chemistry ([@R526]; [@R491]; Tomi c et al. 2014; [@R155]).

Effects on processes involved in elicitation of allergy {#S21}
-------------------------------------------------------

Metal nanomaterials have been shown to have potential to influence elicitation reactions specific to both metals and environmental proteins *in vitro*. With respect to metal allergy, PBMC isolated from women with established allergic sensitivity to palladium were challenged with either 5--10 nm PdNP or palladium salts *in vitro* ([@R395]). Variations in TNFα and IL-10 release were noted between exposures, indicating a potential role for metal solubility on metal-specific allergy elicitation. With respect to environmental allergens, basophils isolated from patients with established sensitivity to common environmental allergens including birch pollen, timothy grass pollen, and house dust mite were exposed to AuNP-conjugated with corresponding allergenic proteins. Stable coronas were formed by all three allergens, but binding of allergen to AuNPs caused enhanced activation of basophils in response to house dust mite challenge, as well as birch pollen in some individuals ([@R387]).

Although lymphocyte cytotoxicity is an immunotoxic effect most often associated with immunosuppression, as major effector cells of both IgE and T-cell-mediated allergic responses, this effect has potential to impact allergic disorders, as well. Accordingly, many metal nano-materials have been shown to be cytotoxic and genotoxic to human and murine lymphocytes *in vitro*. Interestingly, T- and B-lymphocytes have been shown to be more resistant to adverse effects of ZnO NP compared to other immune cell types ([@R145]). Although ion release from ZnO NP and PdNP was correlated to cytotoxicity and alteration in gene expression, DNA damage induced by CoNP was shown to be more severe than that induced by Co ions ([@R188]; [@R486]; [@R370]; [@R457]). Susceptibility to cytotoxicity was shown to be reflective of cell cycle status, explaining the finding that memory T-cells were more sensitive to metal nanomaterial effects compared to naïve T-cells ([@R145]; [@R437]).

Modulation of T-lymphocyte activity by metal nanomaterials also has the potential to significantly influence allergic processes. PdNP, AuNP, CoNP, and GdNP have all been shown to induce differential T~H~1/T~H~2-biased cytokine production by lymphocytes *in vitro* dependent on size, solubility, and hydrophobicity ([@R371]; [@R262]; [@R43]; [@R313]). FeNP suppressed the activity of Kv1.3 channels, which suggests a potential mechanism of lymphocyte cell signaling modulation ([@R521]). Additionally, delays in proliferation, altered mitogen responses, and morphological changes have also been observed by lymphocytes following exposure to various metal nanomaterials ([@R451]; [@R30]; [@R255]; [@R91]).

Knowledge regarding effects of metal nanomaterials specifically on B-cells *in vitro* is limited to AuNP, which have been shown to be size-dependently taken up by B-cells, causing alterations in NF-κB and blimp1/pax5 signaling pathways, and altered secretion of immune-globulins in a size-dependent manner via ([@R441]; [@R241]). The potential for metal nanomaterials to directly alter B-cell processes, such as antigen-specific interactions with T-cells, isotype switching, and affinity maturation, events critical to their effector functions in IgE-mediated allergic disorder such as asthma, remains largely unstudied ([@R266]).

*Knowledge gaps in metal nanomaterial effects on immune cells and processes* in vitro {#S22}
-------------------------------------------------------------------------------------

Formation of the nanomaterial biocorona has been almost exclusively investigated with respect to the adsorption of proteins. However, nanomaterials are also subject to interactions with other macromolecules present in biological fluids, such as nucleic acids and lipids. Adsorption of these molecules may have notable impacts on the immune effects of nanomaterials since different nucleic acids are alarmins recognized by PRR and lipid mediators play critical roles in many aspects of allergic disorders ([@R416]; [@R314]). Accordingly, more research should be directed towards investigating the biological implications of surface-adsorbed macromolecules other than proteins. Similarly, it has been suggested that metal nanomaterials may act as soluble or particulate antigens, but the dynamics of metal antigen generation remains largely unstudied with respect to nanoparticles.

Important considerations for future metal-based nanomaterial allergy studies {#S23}
============================================================================

The potential for metal-based nanomaterials to induce immune effects with implications for allergic disease following exposure by routes other than dermal contact or inhalation is a significant knowledge gap. Nanomaterials are being increasingly incorporated into foods, beverages, supplements, and packaging, rendering ingestion exposures an increasing concern ([@R59]). Ingestion of metal nanomaterials has been associated with altered B-cell distribution, increased levels of IgE and IgG, and splenic toxicity, but the implications of these effects on allergy are unknown ([@R351]; [@R211]; [@R445]). Similar immune effects have been observed following systemic administration of various metal nanomaterials. Although most current uses for metal nanomaterials are not likely to result in systemic exposures, some nanomaterials with expanding biomedical applications present a concern. The significance of this knowledge gap is demonstrated by the numerous adverse effects in patients administered Feraheme (ferumoxytol), an intravenously-administered iron replacement product containing 17--31 nm colloidal Fe~3~O~4~NP ([@R264]). In the 5 years following approval for use by the Food and Drug Administration (FDA) in 2009, 79 anaphylactic reactions were reported, of which 19 were fatal.

As more studies are conducted to advance our understanding of the effects of metal nanomaterials on allergic disease, it should be recognized that accurate assessment is dependent on the evaluation of sample contamination with endotoxin ([@R95]). As a result of production and handling in non-sterile conditions, engineered nanomaterials are often carriers of impurities including LPS, a potent immunoadjuvant ([@R463]). Accordingly, the presence of endotoxin on surfaces of metal nanomaterials could generate a subsidiary but sufficient amount of immunostimulation required to induce allergic sensitization to the metal itself, or to other allergens. Consequently, exposure to immunologically inert metal nanomaterials contaminated with LPS may lead to misidentification of such agents as sensitizers or adjuvants. Many of the studies published prior to this development do not report the presence or absence of endotoxin in samples, and results should be interpreted with caution.

Another consideration for future studies is that the successful correlation of metal nanomaterial physicochemical properties with mechanisms of toxicity is limited by the accurate assessment and reporting of test material characterization. Although thorough material character-ization has become recognized as an indispensable step in nanotoxicity studies, discrepancies in property terminology, evaluation methods, property reporting, and the biological relevance of measured properties complicate comparisons between studies. A notable example of inconsistent property terminology is the tendency for non-discriminate reporting of aggregates and agglomerates of primary particles. The irreversible bonds of aggregates and reversible bonds of agglomerates can impact the effective dose surface area, degree of primary particle dissociation, and other properties that dictate *in vivo* biological effects ([@R205]; [@R136]; Shar[@R270]). Another property subject to inconsistent reporting is nanomaterial surface area. Differences in the material state and method of assessment can generate results representative of different parameters, including volume-specific, geometric, or specific surface area SSA ([@R493]; [@R512]). Although these metrics are often similarly reported by studies, they have been correlated to notable variations in toxic potential ([@R407]). The use of multiple assessment methods and disclosure of potential sources of measurement variation between studies will help accurately compare the impact of properties on toxic potential in future studies.

Accurate evaluation of nanomaterial physicochemical properties and their correlation to toxic effects has become increasingly relevant as emerging nanomaterials challenge the efficacy of traditional occupational exposure limits (OEL). The majority of respiratory occupational exposure limits do not discriminate for material size, so as new metal-based nanomaterials emerge, they are subject to the same mass-derived values enforced for other materials of the same elemental composition. This issue is proving problematic as nanotoxicity studies continue to demonstrate that mass may not be the best dose metric for prediction of pulmonary toxicity ([@R420]). Moreover, as demonstrated by the studies summarized here, metal nanomaterial properties other than mass have been correlated to immune effects following respiratory exposure. Accordingly, size nonspecific OELs may be ineffective in protecting workers from both nanomaterial-induced pulmonary effects, as well as subsequent immune effects ([@R426]). This concern has become increasingly recognized, as NIOSH has recommended size-specific exposure limits for TiO~2~. Despite the recommended time-weighted average exposure limits of 2.4 mg/m^3^ for fine TiO~2~ and 0.3 mg/m^3^ for ultrafine and nanoscale TiO~2~, the agency responsible for regulating compliance with its own established limits(i.e. OSHA) has not yet adopted size-specific OEL values for TiO~2~ (NIOSH 2011).

Conclusions {#S24}
===========

Although there is a growing amount of toxicological data demonstrating the vast potential for adverse immune effects following exposure to metal nanomaterials, advancements in understanding their interactions with biological systems have allowed for their unique characteristics to be harnessed for beneficial applications, as well. Numerous studies have demonstrated the potential utility of metal nanomaterials for novel vaccine adjuvants, drug delivery vehicles, diagnostic approaches, and immunotherapies. However, to optimize the use of metal-based nanomaterials for these and other advantageous purposes, a more complete understanding of their systemic immune effects, mechanisms of immunomodulation, and capacity to induce allergic sensitization is needed.
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###### 

Metal nanomaterial production rates and corresponding applications.

  Nanomaterial         Global production volume (tons)   Applications
  -------------------- --------------------------------- ---------------------------------------------------------------------
  Silicon dioxide      185,000--1,400,000                Nanocomposite filler, cement additive, drug delivery, cosmetics
  Titanium dioxide     60,000--150,000                   Ceramics, sunscreens, construction, energy, cosmetics
  Zinc oxide           32,000--36,000                    Sunscreen, LED and LCD displays, antimicrobial, water filtration
  Aluminum oxide       5000--10,100                      Drilling equipment, energetic fuels, and additives, filtration
  Cerium oxide         880--1400                         Catalysts, slurry polishing, UV absorption, anti-corrosion additive
  Copper oxide         290--570                          Heat transfer, batteries, antimicrobials, sensors, semiconduction
  Silver               135--420                          Biomedicine, antimicrobial textiles, cosmetics, conductive inks
  Antimony tin oxide   120--225                          Electronics, composites, coatings, research
  Zirconium oxide      80--300                           Heat-resistant coatings, ceramics, catalysts, dental composites
  Iron oxide           9--45                             Ground and wastewater cleanup, color imaging, drug delivery
  Nickel               5--20                             Ceramic additive, catalyst, energy absorption, electronics
  Cobalt oxide         5--10                             Electronics, catalysts, drug delivery, solar energy absorption
  Quantum dots         4.5--9                            Photovoltaic devices, photodetecting devices, electronics
  Manganese oxide      2--3.5                            Bleaching agent, biomedical diagnostics, plastics additive
  Gold                 1--3                              Data storage, gene therapy, biosensors, fuel cell additive
  Palladium            --                                Hydrogen sensor, antimicrobial activity, catalysts

Metal nanomaterials, various applications, and reported global production volume for 2014, reported in tons. Adapted from Metal and Metal Oxide Nanomaterials Future Markets Report, [Table 1](#T1){ref-type="table"} (Nanomaterials Future Markets 2015).

###### 

Summary of major findings from studies characterizing the effect of metal nanomaterials on dermal allergy grouped by metal

  Metal      Author/year             Material    Size                                   Animal or cell type                                              Model                     Exposure route                                                     Dose                        Findings
  ---------- ----------------------- ----------- -------------------------------------- ---------------------------------------------------------------- ------------------------- ------------------------------------------------------------------ --------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Aluminum   Varlamova et al. 2015   AI2O3       --                                     M/F BALB/c, CBA/CaLac, out-bred mice and guinea pig              LLNA                      Subcutaneous, intramuscular, intravenous, intra-dermal injection                               No intensification of anaphylaxis systemic reaction, no inflammatory reaction to ConA, no delayed allergic reaction, no redness or edema at site of application
             Brown et al. 2008       AI2O3       50--120 nm                             HaCaT human keratinocytes                                                                  In vitro                                                           10--10,000 μg/mL            24 h exposure resulted in IL-8 expression, IL-1α release, indicating potential for irritation or sensitization
  Cobalt     Choet al. 2012          Co3O4       18.4±5.0nm                             F C57BL/6 mouse                                                  OVA                       Subcutaneous injection                                             25 μg                       Balanced Th1/Th2 response when used as adjuvant, causing higher specific lgG2c and IgGI and less IgE
  Gold       [@R178]                 Au          5.2±1.3nm                              F Japan White Rabbit                                                                       Intradermal injection                                              1 mg                        Azobenzene dye hapten conjugation to AuNP led to high yield of IgG specific to the agent indicating the capacity for AuNP to act as both a carrier and adjuvant
  Iron       [@R446]                 Fe~3~O~4~   58.7 nm                                M BALB/c mouse                                                   OVA                       Intravenously                                                      0.2--10 mg/kg               Decreased footpad swelling, infiltration of macro-phages and T-cells, and IFN-y, IL-6, TNF-α levels
             [@R167]                 Fe~3~O~4~   58.7 nm                                M BALB/c mouse                                                   OVA                       Intravenously                                                      1--100 μg                   Attenuation in TH17 responses
  Silica     [@R66]                  SiO~2~      7nm                                    CBA/N mouse                                                      HSEM LLNA                 Dermal                                                             10--1,000 μg                SiO~2~NP did not induce phototoxicity or skin sensitization
             [@R152]                 SiO~2~      30 nm                                  F NC/Nga slc mouse                                               HDM                       Dermal                                                             20 μl @ 12.5mg/mL           Concurrent exposure to allergen and particles resulted in low-level production of allergen-specific IgG subtypes and increased sensitivity to anaphylaxis
             [@R345]                 SiO~2~      55±6nm                                 M SKH1 mouse                                                     Oxazolone                 Dermal                                                             --                          Functionalized nanoparticles had no impact on allergic response to oxazolone in an ACD model
             [@R462]                 SiO~2~      19nm                                   M BALB/c mouse                                                   DNCB                      Dermal                                                             0.4, 4.0, or 40mg/mL×3d     SiO~2~NP exposure prior to sensitization with DNCB did not alter the stimulation index
  Silver     [@R212]                 Ag          10nm                                   M SPF guinea pig                                                 GPMT                      Intradermal injection                                              0.1 mL @ 1:1 (v/v)          No eye or skin irritation or corrosion. 1/20 guinea pigs developed erythema following subcutaneous injection, leading to its classification as a weak skin sensitizer
                                                                                        M New Zealand White rabbit                                       --                        Occular application                                                100 mg                      No eye irritation effects 1--72 hours after exposure
             Bhol et al. 2005        Ag          \<50nm                                 F BALB/c mouse                                                   DNFB                      Dermal                                                             100 mg 1% nanocrystalline   Reductions in ear swelling, erythema, and inflammation were seen after 4 days of treatment with nanopartide-containing cream
             [@R462]                 Ag          25--85 nm                              M BALB/c mouse                                                   DNCB                      Dermal                                                             0.4, 4.0, or 40mg/mLx3d     Exposure prior to sensitization with DNCB did not alter the stimulation index
             Zelga et al. 2016       Ag          \-                                     Guinea pig                                                       GPMT                      Dermal                                                             2%                          AgNP-containing dressings for chronic wounds were tested via GPMT, wherein 2/10 animals developed slight erythema that resolved after 72 hours, leading to classification as a mild sensitizer
             [@R218]                 Ag          \<100nm                                M Harley Albino guinea pig                                       \-                        Dermal                                                             100--10,000 μg/ml           Dose-dependent increase in number of Langerhans cells recruited to skin
  Titanium   Parket al. 2011         TiO~2~      \<25nm                                 F CBA/N mouse                                                    LLNA                      Dermal                                                             10--1000 μg/mL              TiO~2~ did not induce skin sensitization
                                                                                        F Hartley Albino guinea pig                                      \-                        Dermal                                                             50 μg                       TiO~2~ did not induce phototoxicity or acute cutaneous irritation
             [@R173]                 TiO~2~      12±2nm                                 M BALB/c mouse                                                   DNCB                      Subcutaneous Injection                                             0.004--0.4 mg/mL            TH2 adjuvancy, increased DNCB dermal sensitizer potency
             [@R22]                  TiO~2~      \<25nm                                 F BCC3F1 mouse                                                   \-                        Dermal, Subcutaneous Injection                                     1.25--250 mg/kg             Dermal exposure did not induce auricular lymph node expansion, despite irritancy response at 5% and 10%, no ear swelling, but lymph node cell proliferation resulted following subcutaneous injection
             [@R462]                 TiO~2~      15nm                                   M BALB/c mouse                                                   DNCB                      Dermal                                                             0.4, 4.0, or 40mg/mL×3d     Exposure to 4.0 mg/mL of TiO~2~ prior to sensitiza-tion with DNCB resulted in increased stimulation index
             [@R375]                 TiO~2~                                             New Zealand albino rabbit                                        Acute Dermal Irritation   Dermal                                                             0.5 g                       5 UV-absorbers containing nano-sized particles were assessed for irritation and sensitization potential. Anatase Ti0~2~-containing agent did not induce irritation, but caused mild sensitization
                                                                                        Dunkin-Hartley guinea pig                                        GPMT                      Dermal                                                             0.1 mL/site                 
  Zinc       [@R375]                 ZnO         APS 396 nm, containing nanoparticles   New Zealand albino rabbit                                        Acute Dermal Irritation   Dermal                                                             0.5 g                       5 UV-absorbers containing nano-sized particles were assessed for irritation and sensitization potential. Z11 modifier caused minor dermal irritation and mild sensitization
                                                                                        Dunkin-Hartley guinea pig                                        GPMT                      Dermal                                                             0.1 mL/site                 
             [@R208]                 ZnO         20--50 nm, 13.1 m^2^/g                 M Sprague-Dawley Rat, M New Zealand White rabbit, M guinea pig   GPMT                      Dermal                                                             50%                         ZnONP did not induce dermal sensitization, acute dermal toxicity, irritation, or corrosion

Summary of studies investigating metal nanomaterial immune effects in the skin and select *in vitro* studies using dermal cells, grouped by metal. APS: average particle size, DNCB: dinitrochlorobenzene; GPMT: guinea pig maximization test; HDM: house dust mite; HSEM: Human Skin Equivalent Model; LLNA: Local Lymph Node Assay; OVA: ovalbumin; UV: ultraviolet.

###### 

Summary of major findings from studies comparing the effects of various physicochemical properties of metal nanomaterials on dermal allergy grouped by property of interest.

  Property investigated   Author/year   Metal   Study design           Property variations   Findings
  ----------------------- ------------- ------- ---------------------- --------------------- ------------------------------------------------------------------------------------------------------------
  Size                                          [@R199]                Ag                    RBL-2H3 mast cells F NC/Nga mouse, HDM AD: 40 ng
                                                [@R319]                Si                    XS52 mouse epidermal Langerhans cell, 0.1--1000 ug/mL
                                                Yoshida et al. 2010    Si                    XS52 mouse epidermal Langerhans cell, 0--100 μg/mL
                                                [@R150]                Si                    M NC/Nga mouse HDM ACD Intradermal injection: 250 μg
                                                [@R197]                Au                    Mouse footpad injection OVA
                                                [@R522]                Ti                    M NC/Nga mouse HDM Intradermal injection: 20 μg
                                                lives et al. 2014      Zn                    F BALB/c mice, OVA ACD Dermal application: 16.67 mg/mL
                          CRG                                                                
                                                [@R181]                Zn                    CBA/N Mouse LLNA: 25, 50, or 100 μg/mL ZnONP HSEM EpiDerm skin irritation Draize skin irritation: 50 μg/mL
                                                [@R184]                Si                    M/F hairless C57BL6 mouse DNFB ACD Dermal application
                                                Schaeub[@R252]         Au                    HaCaT human keratinocyte cells 10 μg/mL--25 μg/mL
                          CRY           SA      [@R242]                Si                    J774A.1 mouse macrophages: 0--1,000 ug/mL, 1 or 3 d LLNA: F BALB/c, 1 mg/ ear × 3 tx
  Size                                          [@R281]                Al                    Mice and rabbits Intradermal injection
                                                [@R47]                 Ti                    HEL-30 mouse keratinocytes 0--150 μg/mL 24 h exposure
                                        MOD     Orlowski et al. 2013   Ag                    291.03C mouse keratinocyte 1--10 μg/mL 24 h exposure
                                                Li et al. 2016         Si                    F C57BL/6 mouse 5mg injection

Summary of study design and major findings from studies comparing the effects of various physicochemical properties of metal nanomaterials on dermal allergy grouped by study property of interest. Properties of interest: size, CRY (crystallinity), CRG (surface charge), SA (surface area), and MOD (surface modification). Reported particle size (nm), specific surface area (m2/g), zeta potential (mV), pore volume (cm3/g), in vitro dose concentration (mg/mL). DC: dendritic cell; DNFB: dinitrofluorobenzene; HDM: house dust mite; LC: Langerhans cell; LLNA: Local Lymph Node Assay; HSEM: Human Skin Equivalent Model; OVA: ovalbumin; PEG: poly(ethyleneglycol) modification, PEG-RDG/RGD; ROS: reactive oxygen species; TSLP: thymic stromal lymphopoietin.

###### 

Metal nanomaterials and corresponding physicochemical properties shown to influence immunological processes involved in the development and augmentation of ACD.

  AOP Step                        Metal nanomaterial effect                                                           Metal   Properties implicated   Source
  ------------------------------- ----------------------------------------------------------------------------------- ------- ----------------------- ------------------------------
  Sensitization Bioavailability   Increased potential for nanomaterial penetration of intact skin                     Au      size, crg               [@R224]
                                  Increased potential for nanomaterial penetration of damaged skin                    Ti      size, cry               [@R306]
                                  Increased release of ions from parent nanomaterials                                 Pd      size                    [@R114]
                                  Accumulation of nanomaterial in follicles and skin folds                            Zn      mod                     [@R244]
  Molecular initating event       Increased potential for metal antigen formation                                     Ti      size                    [@R492]
                                  Adsorbed protein conformational changes                                             Au      size                    Bastus et al. 2009
  Cellular response               Selective uptake by LC                                                              Si      size                    [@R319]
                                  Direct activation of DC                                                             Ti      size, cry, mor          Schanen et al. 2009
                                  Release of DAMPs from skin epithelial cells \> activation of DC                     Fe      size                    [@R317]
                                  Release of DAMPs from dermal immune cells \> activation of DC                       Si      size, SA                [@R242]
                                  Altered immunogenicity from adsorption of LPS to surface                            Au      size, mod, hyd          [@R248]
  Organ response                  Depot formation \> altered delivery kinetics                                        Si      agg                     [@R152]
                                  Nanomaterial antigen vehicle \> altered delivery kinetics                           Ti      --                      [@R462]
                                  Accumulation in DC endocytic compartments \> interference with antigen processing   Si      mod, crg                [@R436]
                                  Enhanced capacity for cross-presentation to CD8+ T-cells                            Fe      crg                     [@R311]
                                  Increased TH1 signaling                                                             Co                              Cho et al. 2012
  Elicitation Organism response   Increased permeability of endothelial cells                                         Al      --                      Oesterling et al. 2008
                                  Increased effector T-cell recruitment                                               many    --                      Lozano-Fernandez et al. 2014
                                  Increased number of DC for T-cell activation                                        Si      mod                     Li et al. 2016
                                  Increased number of skin macrophages                                                Fe      --                      Yun et al. 2015
                                  Increased neutrophil influx to the skin                                             Ti      --                      Goncalves, 2011
                                  Increased number of skin mast cells                                                 Ag      size                    Kang H et al. 2017
                                  Altered T-cell response to mitogens/allergens                                       Pd      size, sol               [@R395]
                                  Increased IgE-independent mast cell degranulation                                   many    size, SA, crg           [@R191]
  Chronic effects                 Compromised skin repair mechanisms                                                  Ag      --                      Vieira et al. 2017
                                  Aggravation of allergic lesion severity                                             Si      size                    [@R150]
                                  Compromised barrier integrity \> increased penetration of allergens                 Ag      size, sol               Koohi et al. 2011

Adverse Outcome Pathway (AOP) steps in the sensitization and elicitation phases of allergic contact dermatitis, metal nanomaterials shown to impact individual steps and cells involved, and physicochemical properties associated with effects are shown. Physicochemical properties of interest include size, agglomeration (agg), surface modification (mod), surface area (SA), solubility (sol), surface charge (crg), morphology (mor), crystallinity (cry), hydrophobicity (hyd), surface chemistry (SC). ND (not determined) notation in metal column indicates a study demonstrating a critical role for a specific nanomaterial physicochemical property on the cellular event, but was demonstrated using nonmetal nanomaterials. Findings may be applicable to metals, but have not been demonstrated with individual metal nanomaterials.

###### 

Summary of major findings from studies characterizing the effect of metal nanomaterials on respiratory allergy grouped by metal.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Metal       Author/year              Material                                                                     Size                                   Animal or cell type                                      Mode   Exposure route               Dose                              Findings
  ----------- ------------------------ ---------------------------------------------------------------------------- -------------------------------------- -------------------------------------------------------- ------ ---------------------------- --------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Aluminum    [@R48]                   Al                                                                           48.08±21.0 nm                          Human A549 type ∥ pneumocyte U937 alveolar macrophage\          *In vitro*                   5--500 μg/mL 24 h                 Exposure impaired bacterial phagocytic function
                                                                                                                                                           3:1 co-culture                                                                                                                 

  AI~2~O~3~   32.71 ± 28.3 nm          Exposure impaired bacterial phagocytic function, induction of NFκB pathway                                                                                                                                                                         

  Cerium      Park E-J et al. 2009     CeO~2~                                                                       130 nm                                 M ICR mouse                                              \-     Intratracheal Instillation   50, 100, 200, 400 mg/kg           Differentiation of naive T-cells and TH1 cytokine production

              [@R294]                  CeO~2~                                                                       \<25nm APS 166.5 nm agglomerates       F BALB/c mouse                                           HDM    Intranasal Instillation      75 or 750 μg/kg                   Repeated exposure to CeO~2~NP in the presence of HDM caused increased lung eosinophils, mast cells, plasma IgE, IL-4, and goblet cell metaplasia

  Cobalt      Cho et al. 2012          Co~3~O~4~                                                                    18.4± 5.0 nm                           F Wistar rat                                             \-     Intratracheal\               150 cm^2^ SA                      Exposure caused pulmonary alveolar proteinosis and TH1/TH17 dominant response
                                                                                                                                                                                                                           Instillation                                                   

              Verstaelen et al. 2014   CoO                                                                          7.1 nm                                 BEAS-2B, A549 epithelial cells                                  *In vitro*                   1--60 μg/mL                       Alterations in expression of genes associated with innate immunity, T-cell activation, and leukocyte adhesion

  Copper      Cho et al. 2012          CuO                                                                          23.1 ± 7.2 nm                          F Wistar rat                                             \-     Intratracheal\               150 cm^2^ SA                      No immunoinflammatory reaction
                                                                                                                                                                                                                           Instillation                                                   

              [@R361]                  CuO                                                                          \<50 nm                                F BALB/c mouse                                           OVA    Intranasal Instillation      25, 50, 100 μg/kg                 Increased AHR, IgE and mucus production

              Lai et al. 2018          CuO                                                                          46.5 nm                                C57BL/6 mouse                                            \-     Intranasal delivery          1, 2.5, 5, 10 mg/kg               Aggravated pulmonary inflammation, collagen accumulation and expression of progressive fibrosis markers in lungs

  Iron        [@R361]                  Fe~2~O~3~                                                                    1013 ± 4.2 nm                          M ICR mouse                                              \-     Intratracheal instillation   0.5, 1, or 2 mg/kg                TH1-polarized inflammatory response, GM-CSF, MCP-1, and MIP-1 increase, and increased expression of CD80, CD86, and MHC II expression on lung APCs

              [@R354]                  Fe~3~O~4~                                                                    5.3 + 3.6 nm                           M ICR mouse                                              \-     Intratracheal instillation   250, 500, 1,000 μg/kg             Increases in TH1/TH2 cytokines, B cells, and IgE levels

  Gold        [@R174]                  Au                                                                           40 nm                                  M BALB/c mouse                                           TDI    Aspiration                   40 μL @ 0.8 mg/kg                 3x AHR increase

              Baretto et al. 2015      Au                                                                           6.3 nm                                 Swiss Webster and A/J mouse                              OVA    Intranasal Instillation      6, 60 μg/kg                       Inhibited allergen-induced accumulation of inflammatory cells, pro-inflammatory cytokine production. In A/J mice, AuNPs prevented mucus production and AHR

  Nickel      Cho et al. 2012          NiO                                                                          5.3 nm                                 F Wistar rat                                             \-     Intratracheal Instillation   150 cm^2^ SA                      Exposure caused pulmonary alveolar proteinosis and TH1/TH17 dominant responses

              Baker et al. 2016        Ni                                                                           20 nm                                  M C57BL/6 WT or T-bet−/− mouse                           \-     Aspiration                   4 mg/kg                           Increased airway remodeling in T-bet knockout mice with susceptibility to TH2 responses

              [@R243]                  NiO                                                                          5.3 ± 0.4 nm                           F Wistar rat                                             \-     Intratracheal Instillation   50, 100, 200 cm^2^                Acute neutrophilic inflammation, and eosinophils recruited at days 3 and 4 via eotaxin release

              Chang et al. 2017        NiO                                                                          \-                                     M Wistar rat                                             \-     Intratracheal Instillation   0.015--0.24 mg/kg                 Alterations in TH1/TH2 balance were indicative of nitrative stress and NFk-B activation

  Platinum    [@R353]                  Pt                                                                           20.9 ± 11.4 nm                         M ICR mouse                                              \-     Intratracheal Instillation   \-                                Increase in serum IgE, lung TH2 cytokines, and decrease in CD4/8 ratio

              Onizawa et al. 2009      Pt                                                                           2 ± 0.4 nm                             DBA/2 mouse                                              \-     Intranasal instillation      x3 d                              PtNP exerted protective effects from cigarette smoke, prevented NFk-B activation, and neutrophilic inflammation

  Silica      [@R46]                   Si                                                                           90 nm                                  F BALB/c mouse                                           OVA    Intranasal instillation      0, 10, 100,400 μg                 Co-exposure during sensitization caused dose-dependent enhancement of OVA-specific IgE, lung eosinophils, mucus cell metaplasia, and TH2/TH17 cytokine production

  Silver      Park H et al. 2010       Ag                                                                           6 ± 0.29 nm                            F C57BL/6 mouse                                          OVA    Inhalation                   5 × 20 ppm, 40 mg/kg              Decreased AHR, TH2 cytokines, and ROS levels

              [@R181]                  Ag                                                                           6.0 ± 0.29 nm                          F BALB/c mouse                                           OVA    Inhalation                   20 ppm/40 mg/kg 5× for 24 h       Suppressed mucus production via VEGF signaling alterations

                                                                                                                                                                                                                                                                                          

              [@R465]                  Ag                                                                           33 nm                                  F BALB/c mouse                                           OVA    Inhalation                   3.3 ± 0.7 mg/m^3^ 6h/7 × 7 d      Increased OVA IgE, proteins associated with immune processes were altered

              [@R69]                   Ag                                                                           33 nm                                  F BALB/c mouse                                           OVA    Inhalation                   3.3 mg/m^3^ 6h/d × 7 d            Increased Penh, recruitment of neutrophils, lymphocytes, and eosinophils to the airways

              [@R517]                  Ag                                                                           141 nm                                 F BALB/c mouse                                           OVA    IP Injection                 0.4, 2, 10 mg/kg                  ncreased OVA-IgG and TH2 responses, local activation and recruitment of leukocytes

  Titanium    Ahn et al. 2005          TiO~2~                                                                       0.29 μm                                M Sprague-Dawley rat                                     \-     Intratracheal Instillation   4 mg/kg                           Increased BAL IL-13 levels, IL-13-producing mast cells, and goblet cell hyperplasia

              [@R359]                  TiO~2~                                                                       20 nm                                  ICR mouse                                                \-     Intratracheal Instillation   5, 20, or 50 mg/kg                Increased BAL and serum IgE levels, altered TH1/TH2 cytokines, increased B cell distribution

              Larsen et al. 2009       TiO~2~                                                                       28 nm                                  F BALB/c mouse                                           OVA    IP Injection                 2--250 μg                         TH2 adjuvancy, increased IgE, IgG1, and eosinophil levels

              [@R399]                  TiO~2~                                                                       10 × 40 nm                             F BALC/c/Sca mouse                                       OVA    Inhalation                   2 h/d, 3 d/w, x4 w @ 10 mg/m^3^   Allergic pulmonary inflammation suppressed by TiO~2~NP

              Gustafsson et al. 2011   TiO~2~                                                                       21 nm                                  M Dark Agouti rat                                        \-     Intratracheal instillation   5 mg/kg                           ncreased eosinophil, DC numbers in lungs, lymphocytes recruited mostly CD4+, also included CD8+ T-cells, B-cells, and CD25+ T-cells

              [@R174]                  TiO~2~                                                                       15 nm                                  M BALB/c mouse                                           TDI    Aspiration                   40 μL @ 0.8 mg/kg                 2× increase AHR

              Scarino et al. 2012      TiO~2~                                                                       5 nm APS, 168/171 nm agg.              M Brown Norway rat                                       OVA    Inhalation                   9.4 or 15.7 mg/m^3^               Significantly decreased lung leukocytes and plasma/BAL IL-4, IL-6, and IFN-γ over OVA controls

              [@R192]                  TiO~2~                                                                       21 nm                                  F BALB/c mouse                                           OVA    Inhalation                   32 ± 1 μg                         Aggravated allergic response dependent on dose and timing

              Fu et al. 2014           TiO~2~                                                                       21 nm                                  M Sprague-Dawley rat                                     \-     Intratracheal Instillation   0.5, 4.0, 32 mg/kg 2x/w × 4 w     Deposition in lymph nodes, increased T and B-cell proliferation following mitogen stimulation, enhanced NK activity in spleen, increased B-cells in the blood

              Choi et al. 2014         TiO~2~                                                                       P25                                    M New Zealand White Rabbit                               \-     Intratracheal instillation   10, 50, 250 μg                    Dose-dependent eosinophil influx and inflammation in the lung, but not neutrophil or lymphocyte influx

              [@R139]                  TiO~2~                                                                       21 nm                                  M Dark Agouti rat M Brown Norway rat                     OVA    Inhalation                   168--159 μg/d × 10 d              Exposure decreased eosinophilia in OVA-sensitized DA and BN rats, but neutrophils/lymphocyte increase in DA rats

              [@R297]                  TiO~2~                                                                       4--8 nm                                BALB/c mouse                                             OVA    IP Injection                 200 μg                            Augmented AHR, biochemical markers of damage, and induced a mixed TH1/TH2 response

              [@R210]                  TiO~2~                                                                       75 nm                                  F BALB/c mouse                                           OVA    Inhalation                   50 μg/m^3^ × 3 d                  Exposure exacerbated AHR and inflammation, increases in IL-1, IL-18

  Zinc        [@R400]                  ZnO                                                                          \<50nm                                 F BALB/c mouse                                           OVA    IP Injection                 0.25, 0.5, 1, 3 mg                Administration with OVA caused increased OVA-IgG1, IgE, eosinophil, and mast cell numbers in lungs and spleen

              [@R400]                  ZnO                                                                          \<50nm                                 F BALB/c mouse                                           OVA    IP Injection                 1, 2, 4, and 12 mg/mL             Adjuvant effect on OVA allergy by signaling through TLRs and Src kinase leading to inflammatory responses

              [@R168]                  ZnO                                                                          181.5 nm low dose 360.0 nm high dose   F BALB/c mouse                                           OVA    Aspiration                   0.1/0.5 mg/kg                     Exposure simultaneous to OVA sensitization resulted in eosinophil recruitment and TH2 adjuvancy
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Summary of findings from *in vivo* studies investigating immune effects of metal nanomaterials in the lung and select *in vitro* studies in pulmonary cells, grouped by metal. AHR: airway hyperreactivity; APC: antigen-presenting cell; APS: average particle size; DC: dendritic cell; HDM: house dust mite; IP: intraperitoneal; LPS: lipopolysaccharide; MHC: major histocompatibility complex; OVA: ovalbumin; ROS: reactive oxygen species; RSV: respiratory syncytial virus; TLR: Toll-like receptor; WT: wild-type.
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Summary of major findings from studies comparing the effects of various physicochemical properties of metal nanomaterials on respiratory allergy grouped by property of interest.

  Property investigated   Author/year               Metal   Study design                                  Property variations                                                                   Findings
  ----------------------- ------------------------- ------- --------------------------------------------- ------------------------------------------------------------------------------------- -------------------------------------------------------------------------
  Size                    [@R81]                    Ti      F BALB/cANNCrl mouse                          Fine TiO~2~: 250 nm, 6.6 m^2^/g                                                       Exposure to equal mass doses of fine and ultrafine TiO~2~ resulted in
                                                             Ovalbumin, 200 μg intranasal                 Ultrafine TiO~2~: 29.0 nm, 49.8 m^2^/g                                                 increased TH2 cytokines and serum OVA-specific IgE and IgGI only
                                                                                                                                                                                                 in animals exposed to ultrafine TiO~2~
                          [@R531]                   Si      F BALB/c mouse, Ovalbumin                     Amorphous silica                                                                      Smaller particles induced higher levels of OVA-specific IgE, IgG, and
                                                            Intranasal: 10, 50, or 250 μg/ mouse x3       30, 70, 300, or 1000 nm                                                                IgG1. Splenocytes from mice exposed to the smallest particle pro-
                                                                                                                                                                                                 duced higher levels of TH2 cytokines than other groups.
                          [@R260]                   Ti      Rats, Intratracheal instillation              5 or 200 nm TiO~2~                                                                    Decreased chemotactic ability, expression of Fc receptors/MHC II by
                                                            0.5, 5, or 50 μg/mL                                                                                                                  alveolar macrophages. Phagocytic function was increased at low
                                                                                                                                                                                                 doses and decreased at high doses
                          Chang et al. 2014         Ti      M Sprague Dawley rat                          21 nm TiO~2~NP: 80% anatase, 20% rutile,                                              Increased macrophage accumulation and alteration of TH1/TH2 status
                                                            Intratracheal instillation: x2, x4 w          1--2 μm TiO~2~: anatase                                                               
                                                            0.5, 4, 32 mg/kg                                                                                                                    
                          Ban et al. 2013           Fe      F BALB/c mouse, Ovalbumin                     Submicron Fe~2~O~3~: 147±48nm, 6 m^2^/g                                               High and medium doses of both Fe particles caused decreases in
                                                            Intratracheal instillation:                   Fe~2~O~3~NP: 35±14nm, 39 m^2^/g                                                        eosinophil influx and OVA-specific IgE levels. However, at the low
                                                            4x (100, 250, or 500 μg/mouse)                                                                                                       dose, submicron particles had no effect on allergy, whereas nano-
                                                                                                                                                                                                 particles had an adjuvant effect on the TH2 response to OVA
  SA                      [@R399]                   Ti      F BALB/c/Sca mouse, Ovalbumin                 Rutile TiO~2~NP: \<5 μm, 2 m^2^/g                                                     Allergic pulmonary inflammation was dramatically suppressed in asth-
                                                             Inhalation: 10±2mg/m^3^ × 12                 Rutile TiO~2~NP: 10 × 40 nm, 132 m^2^/g                                                matic mice exposed to either size TiO~2~. Leukocyte number, cyto-
                                                                                                                                                                                                 kines, chemokines, and antibodies were significantly decreased.
                          Parketal. 2015            Si      F BALB/c mouse, Ovalbumin                     Spherical SiNP: 12.7 m^2^/g                                                           Acute SiNP exposure induced significant airway inflammation and
                                                             Intranasal inoculation                       Mesoporous SiNP: 70.6 m^2^/g                                                           AHR. Spherical SiNPs induced the greatest degree of exacerbation
                                                                                                          PEGylated SiNP: 12.7 m^2^/g                                                            of allergic effects in the OVA model
                          [@R144]                   Si      F BALB/c mouse                                Spherical SiNP: 12.7 m^2^/g, 119.6nm                                                  Sensitized mice exposed to S-SiNP and M-SiNP exhibited elevated
                                                             Ovalbumin                                    Mesoporous SiNP: 70.6 m^2^/g, 100.5 nm                                                 AHR over controls. M-SiNPs induced the greatest degree adjuvan-
                                                             Intranasal inoculation: 10 mg/kg 6x          PEGylated SiNP: 12.7 m^2^/g, 439.1 nm                                                  ticity, whereas PEG-SiNP caused the least toxic effects
  MOD                     CRG Seydoux et al. 2016   Au      F BALB/c mouse                                90 nm AuNP:                                                                           APCs preferentially took up cationic AuNPs, causing upregulation of
                                                             AuNP intranasal instillation: 10 μg          NH~2~-PVA, 7.2 mV                                                                      co-stimulatory molecules. Positive AuNPs enhanced OVA-specific
                                                                                                          COOH-PVA 8.2 mV                                                                        CD4+ T-cell stimulation in the lung draining lymph nodes
                          [@R285]                   Si      F BALB/c mouse, Ovalbumin                     Amorphous SiO~2~NP 15 nm:                                                             Uncoated SiO~2~NPs induced proinflammatory and immunomodulatory
                                                             Intratracheal instillation: 50 μg            Uncoated 38 mV, PEGylated 26 mV,                                                       effects with increases in lung inflammatory cells, TH2 cytokines.
                                                                                                          Phosphate-coated 43 mV, Amino-coated 0 mV                                              Amino and phosphate surface modifications mitigated these
                                                                                                                                                                                                 effects, whereas PEG coating did not.
                          [@R340]                   Au      F BALB/c mouse, Ovalbumin                     5 nm AuNP, PEGylated or citrated                                                      Asthmatic condition increased nanoparticle uptake. Systemic uptake is
                                                             Intranasal instillation                                                                                                             higher for PEGylated AuNP compared to citrated AuNPs, but both
                                                                                                                                                                                                 inhibited inflammatory infiltrates and AHR, wherein inhibition was
                                                                                                                                                                                                 more significant following exposure to citrated AuNPS
                          Vennemann                 Zr      F Wistar rat                                  APTS, TODS, PGA, or acrylic acid coated                                               Surface coating had minimal effects on inflammation in the lungs of
                          et al. 2017                        Intratracheal instillation                   9--1 Onm ZrO~2~NPs                                                                     rats, but had significant effects on allergic response.
  Size MOD                Alessandrini              Ag      F BALB/c mice, Ovalbumin                      PVP-coated AgNP: 97 nm, 6.2 m^2^/g, 7mV                                               Ag50-PVP significantly reduced OVA-induced inflammatory infiltrate in
                          et al. 2017                        Intratracheal instillation: 1--50 μg         PVP-coated AgNP: 134nm, 4.5 m^2^/g, 7mV                                                sensitized mice. Lung microbiome was altered dependent
                                                                                                          Citrate-AgNP: 20 nm, 30 m^2^/g, 45 mV                                                  on coating.
                          [@R432]                   Ag      Brown Norway and Sprague-Dawley rats          PVP-coated AgNP: 20 or iiOnm                                                          Smaller AgNPs increased AHR on d 1, which persisted to d 7 for the
                                                             Intratracheal instillation: 0.1 mg/kg        Citrate-capped AgNP: 20 or iiOnm                                                       citrate AgNPs only. 20 nm AgNP was more pro-inflammatory but
                                                                                                                                                                                                 little difference between different surface coatings
                          CRY [@R163]               Zn      F C57BL/6N mouse, Ovalbumin                   Rutile TiO~2~, AI(OH)~3~ surf: 30--50 nm 37.1 m^2^/g                                  Serum total and OVA IgE, IgG1 increased in mice treated with the
                                                    Ti       Pharyngeal aspiration: 50 μg                 ZnO: 21 nm, 49.6 m^2^/g                                                                uncoated ZnO particle. However, ZnCI~2~ did not produce similar
                                                    Si                                                    ZnO, SiO~2~ Surface: 25 nm, unknown SA, ZnCI~2~                                        exacerbations. TiO~2~ and SiO~2~ did not affect OVA-lgE or IgG levels.
                                                                                                          Amorphous SiO~2~: 7nm 300 m^2^/g, 34 nm 80 m^2^/g                                     
  SA                      Sandberg                  Si      LPS-primed RAW264.7 mouse macrophages, pri-   64 nm Si, 650cm^2^/mg                                                                 Non-crystalline SiO~2~ particles in both nano and micron size ranges
                          et al. 2012                        mary rat lung macrophages                    369 nm Si, 90 cm^2^/mg                                                                 induced IL-1β release from LPS-primed macrophages following
                                                             0, 50, 100, 250, 500 μg/mL, 6h               \~20nm Fumed Si (aerosol), 1880cm^2^/mg 500nm-10 μm Fused Si (suprasil), 23cm^2^/mg    uptake, phagosomal leakage, and activation of the NALP3 inflam-
                                                                                                                                                                                                 masome. Particle surface area, reactivity, and uptake all influenced
                                                                                                                                                                                                 the degree of mediator release by cells
                          Vandebriel                Ti      F BALB/c mouse, Ovalbumin                     Uncoated TiO~2~NP:                                                                    Rutile TiO~2~NP caused the greatest increase in OVA-specific serum IgE
                          et al. 2018                        Intranasal exposure: 120 μg TiO~2~           10--30 nm rutile or 10--25 nm anatase                                                  and IgGI. Neutrophils recruited by rutile, but not anatase
                          SOL [@R185]               Co      F Rat, Intratracheal Instillation             CoO: 65.4± 2.8 nm, 92.65% solubility                                                  Soluble CoNP induced eosinophilic inflammation, whereas insoluble
                                                             80, 200, 800 μg/mL @ 0.5 mL                  Co~3~O~4~: 20.2 ± 0.4 nm, 11.46% solubility                                            CoONP induced neutrophilic inflammation
                          [@R65]                    Zn      F Wistar rat                                  10.7±0.7nm ZnONP 50 or 150cm^2^/rat                                                   ZnONP induced eosinophilia, proliferation of airway epithelial cells,
                                                             Intratracheal instillation                   Zn^2+^ ions 92.5 μg/rat                                                                goblet cell hyperplasia, and increased IgE levels, and decreased
                                                                                                                                                                                                 IgA- findings which were also seen following instillation of Zn ions

Summary of study design and major findings from studies comparing the effects of various physicochemical properties of metal nanomaterials on respiratory allergy grouped by study property of interest. Properties of interest: size, CRY (crystallinity), MOR (morphology), MOD (surface modification), CRG (surface charge), and SA (surface area), and SOL (solubility). Reported particle size (nm), specific surface area (m2/g), zeta potential (mV), pore volume (cm3/g), in vitro dose concentration (mg/mL). AHR: airway hyperreactivity; APC: antigen-presenting cell; APTS: aminopropylsilane modification; DC-SIGN: dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin; MDDC: monocyte-derived dendritic cell; MHC: major histocompatibility complex; OVA: ovalbumin; PDI: polydispersity index; PEG: poly(ethylene glycol) modification; PGA: poly(lactic-coglycolicacid) modification; PVA: PVP polyvinylpyrrolidone modification; ROS: reactive oxygen species; TODS: tetraoxidecanoic acid modification

###### 

Metal nanomaterials and corresponding physicochemical properties shown to influence immunological processes involved in the development and augmentation of asthma.

  AOP step                                   Metal nanomaterial effect                                           Metal   Properties implicated   Source
  ------------------------------------------ ------------------------------------------------------------------- ------- ----------------------- ------------------------
   Sensitization Bioavailability             Increased potential for inhalation                                  many    dustiness               Evans et al. 2003
                                             Evasion of uptake by pulmonary macrophages                          Si      size, crg, mod          [@R339]
                                             Evasion of entrapment by pulmonary mucus                            ND      size, crg               [@R316]
                                             Prolonged retention in airways                                      Al      spec, mor               Park et al. 2017
                                             Direct translocation across lung epithelial tissue to lymphatics    Au      size, crg               Kreyling et al. 2014
   Molecular initating event                 Increased potential for metal antigen formation                     Ti      size                    [@R492]
                                             Increased protease activity of protein allergens                    Au      --                      [@R387]
   Cellular response                         Adsorption of LPS to nanomaterial surface                           Au      size, hyd, mod          [@R248]
                                             Increased recruitment of DC to lung                                 Al      mod                     Li et al. 2010
                                             Direct activation of DC                                             Ti      size, cry               [@R511]
                                             Release of DAMPs from immune cells \> activation of DC              Zn      size, mor, SA           Hsaio et al. 2011
                                             Release of DAMPs from epithelial cells \> activation of DC          Ag      size, mod, SA, sol      [@R141]
   Organ response                            Increased CD4^þ^ T-cell presentation efficiency                     Ti      size, mor, cry          Schanen et al. 2009
                                             Increased polarization of CD4^þ^ T-cells to T~H~2 phenotype         Si      size, mod, SA           [@R491]
                                             Increased number of B-cells                                         Ti      --                      [@R359]
                                             Alteration in B-cell expansion/maturation                           Au      size                    [@R241]
                                             Increased production of total IgE                                   Pt      --                      [@R353]
                                             Increased production of allergen-specific IgE                       Zn      size, sol, cry          [@R163]
  Elicitation                                                                                                                                    
    Organism response-early phase reaction   Increased IgE-dependent mast cell degranulation                     Au      size, mod               [@R169]
                                             Increased IgE-independent mast cell degranulation                   many    size, SA, crg           [@R191]
                                             Increased number of lung mast cells                                 Ce      --                      [@R294]
                                             Altered mast cell exocytic function and granule release             Si      SA                      [@R290]
                                             Altered expression of Fc receptors on immune cells                  Ti      size                    [@R260]
    Organism response- late phase reaction   Increased endothelial adhesion molecule expression                  Al      --                      Oesterling et al. 2008
                                             Increased neutrophil recruitment                                    Ag      size, sol               [@R15]
                                             Increased eosinophil recruitment                                    Co      sol                     [@R185]
                                             Increased lymphocyte recruitment                                    Zr      mod                     [@R497]
                                             Increased AHR                                                       Ag      size, mod               [@R432]
                                             Increased airway smooth muscle contractility                        Co/Fe   --                      [@R200]
                                             Mucus cell metaplasia/muus hyeprsecretion                           Ti      --                      [@R60]
    Chronic effects                          Epithelial cell proliferation                                       Zn      sol                     [@R65]
                                             Increased fibroblast MMP activity extracellular matrix remodeling   Ti      size, cry, mor          Armand et al. 2012
                                             Myofibroblast accumulation                                          Cu      --                      Lai et al. 2018

Adverse Outcome Pathway (AOP) steps involved in the sensitization and elicitation phases of asthma, metal nanomaterials shown to impact individual steps, and physicochemical properties associated with effects are shown. Physicochemical properties of interest include size, metal speciation (spec), agglomeration (agg), surface modification (mod), surface area (SA), solubility (sol), surface charge (crg), morphology (mor), crystallinity (cry), and hydrophobicity (hyd). ND (not determined) notation in metal column indicates a study demonstrating a critical role for a specific nanomaterial physicochemical property on the cellular event, but was demonstrated using nonmetal nanomaterials. Findings may be applicable to metals, but have not been demonstrated with individual metal nanomaterials.
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